https://www.lmi.no/2019/06/24/flere-sykehus-starter-egne-als-registre-etter-nasjonal-stopp/ 2019-06-24T10:55:33+00:00 https://www.lmi.no/2019/06/24/godkjente-brystkreftmedisin-en-gledens-dag/ 2019-06-24T10:56:59+00:00 https://www.lmi.no/2019/06/24/oppdaterte-rad-om-vaksiner-ved-utenlandsreiser/ 2019-06-24T10:59:17+00:00 https://www.lmi.no/2019/06/24/helseforetakene-ma-kjope-legemidler-fra-flere-leverandorer/ 2019-06-24T11:00:37+00:00 https://www.lmi.no/2019/06/24/vil-tredoble-medisinlagrene/ 2019-06-24T11:03:43+00:00 https://www.lmi.no/2019/06/24/vi-skal-setje-orsta-pa-verdskartet/ 2019-06-24T11:04:56+00:00 https://www.lmi.no/2019/06/24/beslutningsforum-er-ikke-rigget-for-a-handtere-persontilpasset-behandling/ 2019-06-24T11:06:26+00:00 https://www.lmi.no/2019/06/24/frykter-tilbakeslag-i-kampen-mot-aids-malaria-og-tuberkulose/ 2019-06-24T11:08:27+00:00 https://www.lmi.no/2019/06/24/vi-blir-tjukkere-og-friskere/ 2019-06-24T11:09:48+00:00 https://www.lmi.no/2019/06/24/ous-direktor-trekker-seg/ 2019-06-24T11:11:12+00:00 https://www.lmi.no/2019/06/25/bent-hoie-svarer-om-sen-tilgang-til-kreftbehandling/ 2019-06-25T08:04:09+00:00 https://www.lmi.no/wp-content/uploads/2019/03/hoie2_hoyopploselig-e1553069823244.jpg https://www.lmi.no/2019/06/25/framtidens-stressvaksine-kan-finnes-i-bakken/ 2019-06-25T08:31:22+00:00 https://www.lmi.no/2019/06/25/fiskehelse-loftes-i-norad-prosjekt-i-ghana/ 2019-06-25T09:09:12+00:00 https://www.lmi.no/2019/06/25/kreftceller-med-industriell-ammunisjon/ 2019-06-25T09:11:36+00:00 https://www.lmi.no/2019/06/25/syv-konsekvenser-av-plastforurensning-som-pavirker-deg/ 2019-06-25T09:13:06+00:00 https://www.lmi.no/2019/06/25/prisrevurderingsrekkefolge-2020/ 2019-06-25T09:47:58+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/06/25/referat-21-juni-2019/ 2019-06-25T10:23:51+00:00 https://www.lmi.no/2019/06/25/plassering-av-finansieringsansvar-3/ 2019-06-25T13:36:01+00:00 https://www.lmi.no/2017/08/07/referat-16-juni-2017-2/ 2019-06-26T07:17:56+00:00 https://www.lmi.no/2019/05/06/referat-30-april-2019/ 2019-06-26T07:26:50+00:00 https://www.lmi.no/2019/06/26/referat-19-juni-2019/ 2019-06-26T07:31:49+00:00 https://www.lmi.no/2019/06/26/viiral-inngar-avtale-med-avia-pharma/ 2019-06-26T08:10:22+00:00 https://www.lmi.no/2019/06/26/vi-kan-kanskje-redusere-penicilindoser-med-40-prosent-kan-fa-stor-betydning/ 2019-06-26T08:16:36+00:00 https://www.lmi.no/2019/06/26/vaksinemotstand-er-farlig/ 2019-06-26T08:19:03+00:00 https://www.lmi.no/2019/06/26/slik-ble-de-kvitt-nyoppdaget-virus-hos-rognkjeksen/ 2019-06-26T08:21:17+00:00 https://www.lmi.no/2019/06/26/abbvie-betaler-536-mrd-for-konkurrent/ 2019-06-26T08:27:46+00:00 https://www.lmi.no/2019/06/26/risiko-for-reaktivering-av-hepatitt-b-virus-ved-behandling-med-darzalex/ 2019-06-26T08:30:54+00:00 https://www.lmi.no/2019/06/26/takeda-med-den-forste-godkjente-behandlingen-av-sovnloshet-hos-barn-med-autismespekterforstyrrelser-asd/ 2019-06-26T08:35:51+00:00 https://www.lmi.no/2019/06/26/det-siste-barnet-skal-nas-med-droner/ 2019-06-26T11:26:09+00:00 https://www.lmi.no/2019/06/26/flere-kvinner-enn-menn-far-reseptbelagte-legemidler/ 2019-06-26T11:30:04+00:00 https://www.lmi.no/2019/06/26/hoie-vil-folge-opp-nye-anbudsregler/ 2019-06-26T11:34:03+00:00 https://www.lmi.no/2019/06/26/sa-mye-har-prisen-pa-kreftmedisiner-okt/ 2019-06-26T11:37:21+00:00 https://www.lmi.no/2019/06/27/dobler-stotten-til-kommersialisering-fra-forskning/ 2019-06-27T08:52:06+00:00 https://www.lmi.no/wp-content/uploads/2019/06/1FahlvikNY.jpg https://www.lmi.no/wp-content/uploads/2019/06/FahlvikNY-e1561625425277.jpg https://www.lmi.no/2019/06/27/forskning-gir-ekstra-levetid/ 2019-06-27T09:10:00+00:00 https://www.lmi.no/2019/06/27/skuffet-over-nei-fra-norske-myndigheter/ 2019-06-27T09:13:31+00:00 https://www.lmi.no/2019/06/27/flere-kvinner-enn-menn-far-reseptbelagte-legemidler-2/ 2019-06-27T09:18:05+00:00 https://www.lmi.no/2019/06/27/ny-studie-vanlige-legemidler-knyttes-til-nesten-50-prosent-okt-demensrisiko/ 2019-06-27T09:25:09+00:00 https://www.lmi.no/2019/06/27/fikk-nytt-liv-med-ny-medisin/ 2019-06-27T09:27:11+00:00 https://www.lmi.no/2019/06/27/forskningsradets-policy-for-apen-forskning-ny-mulighet-til-a-gi-innspill/ 2019-06-27T09:29:26+00:00 https://www.lmi.no/2019/06/27/blodkreftforeningen-engasjerer-sivilombudsmannen/ 2019-06-27T09:43:00+00:00 https://www.lmi.no/2019/06/26/cannabis-er-ikke-medisinsk-risikabelt/ 2019-06-27T09:46:44+00:00 https://www.lmi.no/2019/06/27/ny-avtale-med-sykehusinnkjop-hvordan-vet-leverandorer-at-de-har-betalt/ 2019-06-27T10:37:17+00:00 https://www.lmi.no/wp-content/uploads/2019/02/Kai-Mjaanes.jpg https://www.lmi.no/2019/06/28/forslag-til-ny-tiltaksveileder-mot-lakselus/ 2019-06-28T08:26:27+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/06/28/referat-17-juni-2019/ 2019-06-28T09:20:49+00:00 https://www.lmi.no/2019/06/28/offentliggjoring-av-verdioverforinger-2/ 2019-06-28T09:29:30+00:00 https://www.lmi.no/wp-content/uploads/2018/01/Karita-25.jpg https://www.lmi.no/wp-content/uploads/2018/01/Karita-24.jpg https://www.lmi.no/2019/06/28/apnet-biobank-haukeland/ 2019-06-28T09:45:04+00:00 https://www.lmi.no/2019/06/28/livmorhalskreft-vi-kan-forvente-70-prosent-faerre-krefttilfeller/ 2019-06-28T10:44:16+00:00 https://www.lmi.no/2019/07/02/persontilpasset-medisin-umulig-a-praktisere-et-rigid-innforingssystem/ 2019-07-02T08:05:48+00:00 https://www.lmi.no/2019/07/02/legemiddelselskap-kapret-nobelprisvinner/ 2019-07-02T08:07:06+00:00 https://www.lmi.no/2019/07/02/ny-migrenemedisin-godkjent-i-norge/ 2019-07-02T08:08:11+00:00 https://www.lmi.no/2019/07/02/kamp-mot-legemiddelpiratene/ 2019-07-02T08:10:12+00:00 https://www.lmi.no/2019/07/02/et-todelt-helsevesen-kan-bety-liv-eller-dod/ 2019-07-02T08:16:01+00:00 https://www.lmi.no/2019/07/02/det-offentlige-helsevesenet-svikter-pasientene/ 2019-07-02T08:20:14+00:00 https://www.lmi.no/2019/07/02/forskning-gir-ekstra-levetid-2/ 2019-07-02T08:25:48+00:00 https://www.lmi.no/2019/07/02/hvorfor-er-det-en-nyhet-at-noen-blir-smitta-med-meslinger/ 2019-07-02T10:30:34+00:00 https://www.lmi.no/2019/07/02/referat-fra-referansegruppemotet-i-nye-metoder-12-juni/ 2019-07-02T14:37:00+00:00 https://www.lmi.no/2019/07/03/na-kan-du-ta-reisevaksine-pa-apoteket/ 2019-07-03T07:19:15+00:00 https://www.lmi.no/2019/07/03/medisinpodden-tar-for-seg-legemiddelmangel/ 2019-07-03T07:20:18+00:00 https://www.lmi.no/2019/07/03/ny-norsk-hjertemedisin-vil-begrense-skade-ved-hjerteinfarkt/ 2019-07-03T07:25:19+00:00 https://www.lmi.no/2019/07/03/ber-folk-vurdere-vaksine/ 2019-07-03T07:35:56+00:00 https://www.lmi.no/2019/07/03/sammen-kan-menneske-og-maskin-redde-liv/ 2019-07-03T07:41:11+00:00 https://www.lmi.no/2019/07/03/lmis-seniorradgiver-line-walen-har-fatt-plass-i-efpias-arbeidsgruppe-healthcare-systems/ 2019-07-03T12:45:52+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Line-Walen_ny.jpg https://www.lmi.no/wp-content/uploads/2019/04/Line-Walen_ny.jpg https://www.lmi.no/2019/07/04/stordalen-refset-naeringslivets-lave-kvinneandel-na-svarer-kvinnene-lmi-kommenterer/ 2019-07-04T07:30:41+00:00 https://www.lmi.no/2019/07/04/ny-migrenemedisin-som-hemmer-cgrp-pa-markedet/ 2019-07-04T07:31:40+00:00 https://www.lmi.no/2019/07/04/saerskilte-fullmaktshjemler-til-statens-legemiddelverk-ved-brexit-uten-en-overgangsperiode/ 2019-07-04T07:32:43+00:00 https://www.lmi.no/2019/07/04/studie-gravides-medisinbruk-pavirker-ikke-forskolebarns-atferd/ 2019-07-04T07:33:42+00:00 https://www.lmi.no/2019/07/04/krav-om-lenke-til-legemiddelverkets-informasjonsside-om-netthandel/ 2019-07-04T07:42:03+00:00 https://www.lmi.no/2019/07/04/rapport-hjertesvikt-vil-koste-over-60-milliarder-i-2030/ 2019-07-04T09:26:47+00:00 https://www.lmi.no/2019/07/05/eu-kommisjonen-med-ny-versjon-av-qa-om-kliniske-studier/ 2019-07-05T07:48:54+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Helsedata-kliniske-studier_org.jpg https://www.lmi.no/2019/07/05/mangel-pa-fucithalmic/ 2019-07-05T09:04:58+00:00 https://www.lmi.no/2019/07/05/catapresan-25-mikrog-avregistreres/ 2019-07-05T09:06:06+00:00 https://www.lmi.no/2019/07/05/nycoplus-b-total-tabletter-og-nycoplus-b-tonin-avregistreres/ 2019-07-05T09:07:06+00:00 https://www.lmi.no/2019/07/05/positiv-til-forskning/ 2019-07-05T09:08:59+00:00 https://www.lmi.no/2019/07/05/lmi-med-innspill-til-regjeringens-strategi-for-kunstig-intelligens/ 2019-07-05T13:19:22+00:00 https://www.lmi.no/wp-content/uploads/2019/07/franck-v-zbLW0FG8XU8-unsplash.jpg https://www.lmi.no/2019/07/08/dataintegritet-og-revisjonsspor-for-gmp-relevante-data/ 2019-07-08T08:15:21+00:00 https://www.lmi.no/2019/07/08/trump-lover-verdens-laveste-medisinpriser-i-usa/ 2019-07-08T08:16:27+00:00 https://www.lmi.no/2019/07/08/legemiddelmangelen-er-skremmende-og-har-aldri-vaert-sa-ille-som-na-krever-innlogging/ 2019-07-08T08:17:45+00:00 https://www.lmi.no/2019/07/08/retrett-for-apotekenes-regulator/ 2019-07-08T09:13:45+00:00 https://www.lmi.no/2019/07/09/pasienter-med-lungekreft-kan-fa-ekstra-levetid-og-okt-livskvalitet-med-ny-medisin/ 2019-07-09T07:51:43+00:00 https://www.lmi.no/2019/07/09/targovaxstudie-med-effekt-hos-en-av-tre-med-senstadie-foflekkreft/ 2019-07-09T07:53:48+00:00 https://www.lmi.no/2019/07/10/tysk-kreftselskap-henter-28-milliarder-kroner/ 2019-07-10T08:00:28+00:00 https://www.lmi.no/2019/07/10/vi-har-en-ramme-for-totale-ressurser-og-ma-derfor-prioritere/ 2019-07-10T08:01:42+00:00 https://www.lmi.no/2019/07/10/far-millioner-til-a-forske-pa-hiv/ 2019-07-10T08:02:41+00:00 https://www.lmi.no/2019/07/11/1085-bivirkningsmeldinger-etter-hpv-vaksine/ 2019-07-11T07:51:48+00:00 https://www.lmi.no/2019/07/11/storbritannia-tester-ny-finansiering-for-antibiotikaproduksjon/ 2019-07-11T07:52:52+00:00 https://www.lmi.no/2019/07/09/nye-funn-for-tarmkreft-medisiner-markant-fremskritt/ 2019-07-11T09:09:09+00:00 https://www.lmi.no/2019/07/12/nordic-nanovector-har-registrert-siste-pasient-i-studie/ 2019-07-12T08:31:48+00:00 https://www.lmi.no/2019/07/12/eksplosjon-i-salg-av-reseptbelagt-skabbmedisin-kan-tyde-pa-resistens/ 2019-07-12T08:33:07+00:00 https://www.lmi.no/2019/07/12/fikk-ikke-bruke-helse-algortime-na-vil-forskerne-at-lovverket-knyttet-til-helsedata-skal-endres/ 2019-07-12T08:33:55+00:00 https://www.lmi.no/2019/07/16/fremdeles-mye-som-mangler-pa-verifikasjonssystemet/ 2019-07-16T07:52:57+00:00 https://www.lmi.no/2019/07/16/fikk-nei-til-immunterapi-uforsvarlig-mener-helsetilsynet/ 2019-07-16T07:53:57+00:00 https://www.lmi.no/2019/07/16/legeleder-om-off-label-avgjorelse-en-liten-revolusjon/ 2019-07-16T07:55:01+00:00 https://www.lmi.no/2019/07/16/kritisk-medisinmangel-mener-norge-kan-lage-de-viktigste-medisinene-selv/ 2019-07-16T07:56:18+00:00 https://www.lmi.no/2019/07/16/medisinmangel-kan-begrenses-lmi-kommenterer-krever-innlogging/ 2019-07-16T07:57:34+00:00 https://www.lmi.no/2019/07/16/hilsen-fra-tidligere-styreledere-i-lmi/ 2019-07-16T08:17:11+00:00 https://www.lmi.no/wp-content/uploads/2019/07/tidligere-styreledere-LMI.jpg https://www.lmi.no/2019/07/16/targovax-starter-ekspansjonsdel-av-fase-i-ii-studie/ 2019-07-16T08:20:08+00:00 https://www.lmi.no/2019/07/17/helsejurist-forventer-flere-pasientklage-saker-i-fremtiden/ 2019-07-17T07:55:57+00:00 https://www.lmi.no/2019/07/17/mangel-pa-metformin-500-mg-og-1000-mg-tabletter/ 2019-07-17T07:56:59+00:00 https://www.lmi.no/2019/07/17/ett-av-ti-barn-fikk-ikke-vaksine-i-2018/ 2019-07-17T08:09:57+00:00 https://www.lmi.no/2019/07/17/hoie-glad-for-at-pasienter-kan-klage/ 2019-07-17T08:10:47+00:00 https://www.lmi.no/2019/07/18/mangel-pa-cardizem-90-mg-depottabletter/ 2019-07-18T08:02:12+00:00 https://www.lmi.no/2019/07/18/fagdirektor-tilfreds-med-avklaring-om-immunterapi/ 2019-07-18T08:03:18+00:00 https://www.lmi.no/2019/07/19/kraftig-okning-i-danskenes-bruk-av-medisinsk-cannabis/ 2019-07-19T10:14:54+00:00 https://www.lmi.no/2019/07/19/flere-hundre-nordmenn-har-insulinpumper-med-sikkerhetsrisiko/ 2019-07-19T10:16:16+00:00 https://www.lmi.no/2019/07/22/lege-medisin-vedtak-kan-bety-at-20-til-30-pasienter-i-aret-vil-fa-dekket-behandling/ 2019-07-22T08:26:03+00:00 https://www.lmi.no/2019/07/22/video-av-presentasjoner-fra-markedstilgangsutvalget/ 2019-07-22T09:06:29+00:00 https://www.lmi.no/2019/07/23/studie-multiresistent-malaria-sprer-seg-i-sorost-asia/ 2019-07-23T08:42:33+00:00 https://www.lmi.no/2019/07/23/pasientombud-frykter-storre-helseforskjeller/ 2019-07-23T08:58:55+00:00 https://www.lmi.no/2019/07/24/dobbelt-sa-mange-vaksinerer-seg-mot-rabies/ 2019-07-24T09:24:32+00:00 https://www.lmi.no/2019/07/24/vaksinepille-for-bjorkepollen-er-godkjent-i-norge/ 2019-07-24T09:26:25+00:00 https://www.lmi.no/2019/07/24/ous-vil-vurdere-folger-av-medisin-vedtak-over-sommeren/ 2019-07-24T09:36:31+00:00 https://www.lmi.no/2019/07/25/pharmaq-hadde-nesten-en-milliard-kroner-i-inntekter-i-fjor/ 2019-07-25T10:28:52+00:00 https://www.lmi.no/2019/07/02/salgstall-fra-farmastat-for-juni-2019/ 2019-07-29T07:10:35+00:00 https://www.lmi.no/2019/07/29/bent-hoie-svarer-om-slvs-metodevurderinger-konklusjoner/ 2019-07-29T08:51:12+00:00 https://www.lmi.no/wp-content/uploads/2019/03/hoie2_hoyopploselig-e1553069823244.jpg https://www.lmi.no/2019/07/29/pfizer-og-mylan-vil-sla-sammen-produksjon/ 2019-07-29T09:50:42+00:00 https://www.lmi.no/2019/07/29/tror-pasienters-rett-til-a-klage-vil-svekkes/ 2019-07-29T09:55:32+00:00 https://www.lmi.no/2019/07/30/horing-om-tilgjengeliggjoring-av-helsedata/ 2019-07-30T07:12:54+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/07/30/fda-godkjenner-injeksjonsfri-hypoglykemi-behandling/ 2019-07-30T08:45:14+00:00 https://www.lmi.no/2019/07/30/hvor-fort-oppdager-vi-smerte/ 2019-07-30T08:50:00+00:00 https://www.lmi.no/2019/07/30/gar-du-pa-en-av-disse-106-medisinene-ikke-spis-grapefrukt/ 2019-07-30T08:53:11+00:00 https://www.lmi.no/2019/07/30/tom-for-metformin-ikke-fortvil/ 2019-07-30T08:54:52+00:00 https://www.lmi.no/2019/07/30/okt-brukermedvirkning-i-helseforskning/ 2019-07-30T08:57:16+00:00 https://www.lmi.no/2019/07/30/aesgp-euro-otc-news-june-2019/ 2019-07-30T09:38:26+00:00 https://www.lmi.no/2019/07/31/forste-eu-godkjente-cannabismedisin/ 2019-07-31T09:47:25+00:00 https://www.lmi.no/2019/07/31/selv-fa-skottelus-er-et-problem-for-laksen/ 2019-07-31T09:50:57+00:00 https://www.lmi.no/2019/07/31/advarer-gravide-mot-bruk-av-ms-legemiddel/ 2019-07-31T09:53:32+00:00 https://www.lmi.no/2019/07/31/japansk-gigant-kjoper-norsk-ai-startup-leder-vei-i-kampen-mot-kreft/ 2019-07-31T09:55:09+00:00 https://www.lmi.no/2019/07/31/ledig-plass-i-markedstilgangsutvalget-underutvalg-for-offentlige-anskaffelser/ 2019-07-31T10:13:06+00:00 https://www.lmi.no/wp-content/uploads/2017/07/utvalgillustrasjon.jpg https://www.lmi.no/2019/07/31/who-slar-alarm-om-hiv-resistens/ 2019-07-31T10:39:22+00:00 https://www.lmi.no/2019/07/31/merck-salget-dratt-opp-av-kreftmedisin/ 2019-07-31T11:44:54+00:00 https://www.lmi.no/2019/07/30/en-ny-var-for-bakteriofager-2/ 2019-07-31T12:34:40+00:00 https://www.lmi.no/wp-content/uploads/2019/07/bakteriofag-1.jpg https://www.lmi.no/2019/07/31/referat-fra-18-juni-2019-mote-med-slv/ 2019-07-31T12:57:37+00:00 https://www.lmi.no/2019/07/31/referat-14-juni-2019/ 2019-07-31T13:14:44+00:00 https://www.lmi.no/2019/08/01/aftenposten-mener-berettiget-soksmal-mot-legemiddelindustrien/ 2019-08-01T07:42:12+00:00 https://www.lmi.no/2019/08/01/langtidsvirkende-insulin-ogsa-for-type-2/ 2019-08-01T07:49:27+00:00 https://www.lmi.no/2019/08/01/et-av-de-storste-tulleforbudene/ 2019-08-01T07:51:33+00:00 https://www.lmi.no/2019/08/01/har-pavist-ny-klamydiavariant/ 2019-08-01T07:53:23+00:00 https://www.lmi.no/2019/08/01/sjekk-hvilke-vaksiner-du-bor-ta-i-sommer/ 2019-08-01T08:00:31+00:00 https://www.lmi.no/2019/08/01/redder-liv-hver-eneste-dag/ 2019-08-01T08:21:14+00:00 https://www.lmi.no/2019/08/01/salgstall-fra-farmastat-for-juli-2019/ 2019-08-01T10:58:43+00:00 https://www.lmi.no/2019/08/02/gikk-i-kjelleren-etter-alvorlig-kreftsykdom/ 2019-08-02T07:13:13+00:00 https://www.lmi.no/2019/08/02/utvikler-en-p-pille-som-tas-en-gang-i-maneden/ 2019-08-02T07:15:12+00:00 https://www.lmi.no/2019/08/02/blir-ny-divisjonsleder-i-helsedirektoratet/ 2019-08-02T07:17:30+00:00 https://www.lmi.no/2019/08/02/nye-kjoreregler-for-rapportering-av-legemiddelmangel/ 2019-08-02T07:19:37+00:00 https://www.lmi.no/2019/08/05/motgift-skal-stagge-alzheimer/ 2019-08-05T08:19:45+00:00 https://www.lmi.no/2019/08/05/denne-tabletten-kan-redde-liv/ 2019-08-05T08:21:47+00:00 https://www.lmi.no/2019/08/05/gry-og-dotrene-har-samme-sjeldne-sykdom/ 2019-08-05T08:23:52+00:00 https://www.lmi.no/2019/08/05/forskere-mener-store-problemer-i-helsevesenet-kan-loses-med-humaniora/ 2019-08-05T08:26:24+00:00 https://www.lmi.no/2019/08/05/lov-og-bransjekurs-host-2019/ 2019-08-05T09:57:59+00:00 https://www.lmi.no/wp-content/uploads/2019/03/lovkurs_digforside-2019_uten-tekst.jpg https://www.lmi.no/wp-content/uploads/2019/08/Deltagerne-Lov-og-bransje.jpeg https://www.lmi.no/wp-content/uploads/2016/08/Lars.jpg https://www.lmi.no/2019/08/06/flere-kunne-ha-vaert-reddet/ 2019-08-06T10:12:40+00:00 https://www.lmi.no/2019/08/06/svensk-forskning-identifiserer-nye-astma-gener/ 2019-08-06T10:15:01+00:00 https://www.lmi.no/2019/08/06/legemiddelmangel-hva-kan-relis-bidra-med/ 2019-08-06T10:17:14+00:00 https://www.lmi.no/2019/08/07/bayers-vitravki-ligger-an-til-a-bli-forste-tumoragnostisk-terapi-i-eu-etter-chmp-anbefaling/ 2019-08-07T10:19:29+00:00 https://www.lmi.no/2019/08/07/sanofis-dupixent-blir-utvidet-i-europa-til-a-dekke-tenaringer-med-atopisk-eksem/ 2019-08-07T10:21:17+00:00 https://www.lmi.no/2019/08/07/eli-lillys-emgality-knuser-alle-fase-3-sluttpunkter/ 2019-08-07T10:24:27+00:00 https://www.lmi.no/2019/08/07/innovasjon-i-helsevesenet-hvordan-far-vi-hoyrehanden-og-venstrehanden-til-a-jobbe-sammen/ 2019-08-07T10:26:29+00:00 https://www.lmi.no/2019/08/07/mangel-pa-betablokker/ 2019-08-07T10:28:49+00:00 https://www.lmi.no/2019/08/07/varsleren-som-ikke-lar-seg-kneble/ 2019-08-07T10:31:48+00:00 https://www.lmi.no/2019/08/07/mindre-vaksinering-i-juli/ 2019-08-07T10:33:35+00:00 https://www.lmi.no/2019/08/08/ema-anbefaler-godkjenning-av-behandling-med-roches-medisin-tecentriq-i-kombinasjon-med-kjemoterapi-for-pasienter-med-utbredt-smacellet-lungekreft/ 2019-08-08T09:02:42+00:00 https://www.lmi.no/2019/08/08/i-kroll-for-multidose/ 2019-08-08T09:04:52+00:00 https://www.lmi.no/2019/08/08/novo-nordisk-har-kjopt-pillefabrikk-i-north-carolina/ 2019-08-08T09:07:03+00:00 https://www.lmi.no/2019/08/08/apotekene-tommes-for-aspirin-lege-advarer/ 2019-08-08T09:09:31+00:00 https://www.lmi.no/2019/08/08/en-million-er-rammet-susann-34-er-usynlig-syk/ 2019-08-08T09:12:36+00:00 https://www.lmi.no/2019/08/08/mote-15-mai-2019/ 2019-08-08T09:43:14+00:00 https://www.lmi.no/2019/08/09/novo-nordisk-okte-omsetningen-med-ni-prosent/ 2019-08-09T09:08:35+00:00 https://www.lmi.no/2019/08/09/nye-metoder-har-mottatt-fullstendig-metodevurdering-av-ms-legemidler/ 2019-08-09T09:10:42+00:00 https://www.lmi.no/2019/08/09/hva-er-solidaritet/ 2019-08-09T09:14:30+00:00 https://www.lmi.no/2019/08/12/medisinmangelen-truer-pasientsikkerheten/ 2019-08-12T09:40:44+00:00 https://www.lmi.no/2019/08/12/1-av-5-har-ikke-tillit-til-det-offentlige-helsevesen-ved-livstruende-kreftsykdom/ 2019-08-12T09:42:23+00:00 https://www.lmi.no/2019/08/12/en-pille-for-alt-som-er-ille/ 2019-08-12T09:44:15+00:00 https://www.lmi.no/2019/08/12/forventer-ny-vurdering-av-ms-medisin/ 2019-08-12T09:45:51+00:00 https://www.lmi.no/2019/08/12/syklet-for-kreftsaken/ 2019-08-12T09:50:21+00:00 https://www.lmi.no/2019/08/12/reklamekurs-5-november-2019/ 2019-08-12T11:07:00+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Reklame_Dig_Forside-NY.jpg https://www.lmi.no/2019/08/13/ny-nettside-om-legemiddelmangel/ 2019-08-13T07:53:37+00:00 https://www.lmi.no/2019/08/13/industrivennlig-politikk-gagner-pasientene/ 2019-08-13T07:55:29+00:00 https://www.lmi.no/2019/08/13/mogleg-gjennombrot-i-kampen-mot-ebola/ 2019-08-13T07:57:21+00:00 https://www.lmi.no/2019/08/13/fda-melder-om-manipulasjon-av-data-for-nytt-sma-legemiddel/ 2019-08-13T07:59:15+00:00 https://www.lmi.no/2019/08/13/helsenaeringsmeldingen-nye-muligheter-for-bioingeniorer/ 2019-08-13T08:01:17+00:00 https://www.lmi.no/2019/08/13/saker-fra-dm-pharma-2/ 2019-08-13T08:08:23+00:00 https://www.lmi.no/2019/08/13/arendalsuka-er-i-gang/ 2019-08-13T12:36:19+00:00 https://www.lmi.no/wp-content/uploads/2019/08/karita-skjermdump.jpg https://www.lmi.no/2019/04/23/legemiddelindustrien-i-arendalsuka-2/ 2019-08-13T15:40:07+00:00 https://www.lmi.no/wp-content/uploads/2019/04/sunset.jpeg https://www.lmi.no/2019/08/13/industrien-i-arendalsuka-tirsdag/ 2019-08-13T17:19:56+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Espen.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Merck.jpg https://www.lmi.no/wp-content/uploads/2019/08/Espen.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Bilde1AbbVie-m%C3%B8tet.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Bilde2AbbVie.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Bayer.jpg https://www.lmi.no/2019/08/14/inspire-en-mulighet-for-okt-tilgang-pa-nye-kreftlegemidler/ 2019-08-14T07:02:36+00:00 https://www.lmi.no/wp-content/uploads/2019/06/INSPIRE-2019-HELDEKK-SLIDE-e1561636385335.jpg https://www.lmi.no/2019/08/14/en-barnehage-i-bamble-registrerte-skabb-hos-atte-forskjellige-barn-i-fjor-host-vinter/ 2019-08-14T07:19:52+00:00 https://www.lmi.no/2019/08/14/alle-bor-fa-livreddende-trening-pa-sykehus/ 2019-08-14T07:21:44+00:00 https://www.lmi.no/2019/08/14/proteiner-avslorer-kreftsvulstens-hemmeligheter/ 2019-08-14T07:23:16+00:00 https://www.lmi.no/2019/08/14/har-sammenlignet-lungekreft-behandlingstilbudet-i-europa/ 2019-08-14T07:24:54+00:00 https://www.lmi.no/2019/08/14/optinose-taper-millioner/ 2019-08-14T07:26:22+00:00 https://www.lmi.no/2019/08/14/dette-skjer-i-arendal-i-dag/ 2019-08-14T07:43:48+00:00 https://www.lmi.no/wp-content/uploads/2019/08/karita-skjermdump2.jpg https://www.lmi.no/2019/08/14/tiden-er-inne-for-a-slippe-oss-til/ 2019-08-14T11:26:43+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Karita-p%C3%A5-Radiumpodkast.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Karita-p%C3%A5-Radiumpodkast.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Radiumsalen.jpeg https://www.lmi.no/2019/08/14/industrien-i-arendalsuka-onsdag/ 2019-08-14T18:59:08+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Karita-2.jpg https://www.lmi.no/wp-content/uploads/2019/08/Karita-p%C3%A5-Radiumpodkast-1.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Karita-2.jpg https://www.lmi.no/wp-content/uploads/2019/08/unge-oppfinnere.jpg https://www.lmi.no/wp-content/uploads/2019/08/celgene.jpg https://www.lmi.no/wp-content/uploads/2019/08/Line.jpg https://www.lmi.no/wp-content/uploads/2019/08/Takeda.jpg https://www.lmi.no/wp-content/uploads/2019/08/image00001-1.jpeg https://www.lmi.no/wp-content/uploads/2019/08/amcham.jpeg https://www.lmi.no/2019/08/15/det-er-bare-sa-goy/ 2019-08-15T06:57:10+00:00 https://www.lmi.no/wp-content/uploads/2019/08/karita-skjermdump4.jpg https://www.lmi.no/2019/08/15/tatt-for-promille-etter-bruk-av-smerteplaster/ 2019-08-15T07:11:57+00:00 https://www.lmi.no/2019/08/15/saker-fra-dm-pharma-3/ 2019-08-15T07:15:13+00:00 https://www.lmi.no/2019/08/15/tromso-forskere-undersoker-om-blabaer-kan-bli-kur-mot-demens/ 2019-08-15T07:17:18+00:00 https://www.lmi.no/2019/08/15/kreftspesialist-frykter-offentlig-forrang-for-dem-med-best-rad/ 2019-08-15T07:18:48+00:00 https://www.lmi.no/2019/08/15/britene-forbereder-hard-brexit-vil-etablere-ekspresstransport-for-medisiner/ 2019-08-15T07:20:14+00:00 https://www.lmi.no/2019/08/15/mangel-pa-enda-flere-legemidler/ 2019-08-15T07:21:49+00:00 https://www.lmi.no/2019/08/15/fagdirektor-i-helse-vest-inspire-kan-hjelpe-beslutningforum-stort/ 2019-08-15T07:23:34+00:00 https://www.lmi.no/2019/08/14/inspire-na-gar-vi-fra-en-overordnet-politikk-til-konkrete-losninger/ 2019-08-15T11:05:55+00:00 https://www.lmi.no/wp-content/uploads/2019/08/image00001.jpeg https://www.lmi.no/wp-content/uploads/2019/08/image00001.jpeg https://www.lmi.no/2019/08/14/helsenaering-dette-skal-vi-bli-best-pa/ 2019-08-16T05:41:59+00:00 https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/2019/08/15/persontilpasset-behandling-krever-tilpassede-metoder/ 2019-08-16T05:46:33+00:00 https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/2019/08/16/mener-nye-kreftmedisiner-styrker-et-todelt-helsevesen/ 2019-08-16T06:13:37+00:00 https://www.lmi.no/2019/08/16/ny-cannabismedisin-ingen-vidunderkur-sier-professor/ 2019-08-16T06:15:51+00:00 https://www.lmi.no/2019/08/16/ikke-kjop-kosttilskudd-med-pastand-om-effekt-pa-helse/ 2019-08-16T06:18:08+00:00 https://www.lmi.no/2019/08/16/derfor-er-det-legemiddelmangel/ 2019-08-16T06:21:05+00:00 https://www.lmi.no/2019/08/16/sykehusene-ma-laere-av-hjertelegene-i-arendal/ 2019-08-16T07:55:57+00:00 https://www.lmi.no/2019/08/16/industrien-i-arendalsuka-torsdag/ 2019-08-16T09:11:31+00:00 https://www.lmi.no/wp-content/uploads/2019/08/karita-debatt.jpg https://www.lmi.no/wp-content/uploads/2019/08/fk-debatt.jpg https://www.lmi.no/wp-content/uploads/2019/08/Susann.jpg https://www.lmi.no/wp-content/uploads/2019/08/karita-debatt.jpg https://www.lmi.no/wp-content/uploads/2019/08/sanofi-hud.jpeg https://www.lmi.no/wp-content/uploads/2019/08/sanofi-hjerte.jpg https://www.lmi.no/wp-content/uploads/2019/08/Hom-sanofi.jpg https://www.lmi.no/2019/08/19/flere-og-flere-far-adhd-medisin/ 2019-08-19T10:38:47+00:00 https://www.lmi.no/2019/08/19/ema-gir-klarsignal-for-ny-cannabismedisin-ingen-vidunderkur-sier-professor/ 2019-08-19T10:40:50+00:00 https://www.lmi.no/2019/08/19/britene-star-overfor-mangel-pa-mat-drivstoff-og-medisiner-ved-brexit/ 2019-08-19T10:46:31+00:00 https://www.lmi.no/2019/08/19/danmark-forsok-med-rehabilitering-av-brystkreftopererte-i-kommunen/ 2019-08-19T10:48:17+00:00 https://www.lmi.no/2019/08/19/kan-leger-vaere-til-nytte-for-als-pasientene/ 2019-08-19T10:50:02+00:00 https://www.lmi.no/2019/08/19/sintef-her-er-24-nye-naeringsmuligheter-for-norge/ 2019-08-19T10:52:50+00:00 https://www.lmi.no/2019/04/12/tall-og-fakta-2019/ 2019-08-19T12:16:24+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Tall-og-fakat-forside-1.jpg https://www.lmi.no/wp-content/uploads/2019/04/Tall-og-fakat-forside.jpg https://www.lmi.no/2019/08/20/kurs-i-regi-av-norsk-farmasoytisk-selskap/ 2019-08-20T07:51:56+00:00 https://www.lmi.no/2019/08/20/arendalsuka-2019-oppsummert-se-video/ 2019-08-20T13:07:01+00:00 https://www.lmi.no/wp-content/uploads/2019/08/arendal-Oppsummert.jpg https://www.lmi.no/2019/08/20/referat-7-august-2019-felles-mote-med-slv/ 2019-08-20T13:30:20+00:00 https://www.lmi.no/2019/08/21/kripos-bekymret-for-ny-trend-tommy-26-ble-avhengig-av-tramadol/ 2019-08-21T07:11:06+00:00 https://www.lmi.no/2019/08/21/dra-forum-planlegger-medlemsmote-12-november-2019/ 2019-08-21T07:22:35+00:00 https://www.lmi.no/2019/08/21/nordic-nanovector-henter-teknologidirektor-fra-bayer/ 2019-08-21T07:30:49+00:00 https://www.lmi.no/2019/08/20/er-statmed-den-nye-oljen/ 2019-08-21T08:55:33+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Tidsskriftet2.png https://www.lmi.no/2019/08/21/frokostmote-om-helsedatasoknad-en-praktisk-tilnaerming/ 2019-08-21T09:07:17+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Helsedata-kliniske-studier_org.jpg https://www.lmi.no/2019/08/21/hoie-har-svart-morland-om-legemiddelberedskap/ 2019-08-21T09:52:58+00:00 https://www.lmi.no/2019/08/15/vi-trenger-samarbeid-og-nye-metoder/ 2019-08-21T11:26:39+00:00 https://www.lmi.no/wp-content/uploads/2019/08/fk-line.jpg https://www.lmi.no/wp-content/uploads/2019/08/fk-line.jpg https://www.lmi.no/wp-content/uploads/2019/08/fk-aamdal.jpg https://www.lmi.no/wp-content/uploads/2019/08/fk-debatt.jpg https://www.lmi.no/2019/08/21/styremote-i-lmi-28-august/ 2019-08-21T16:27:54+00:00 https://www.lmi.no/wp-content/uploads/2019/03/Styret-2019.jpg https://www.lmi.no/wp-content/uploads/2019/04/Veronika-Barrabes-e1559897653464.jpg https://www.lmi.no/2019/08/22/dramatisk-okning-i-beslag-av-legemiddel-frykter-amerikanske-tilstander/ 2019-08-22T07:04:18+00:00 https://www.lmi.no/2019/08/22/50-bedrifter-og-politikere-ville-ga-for-naeringslivet/ 2019-08-22T07:05:58+00:00 https://www.lmi.no/2019/08/23/arendalsuka-lover-godt-for-helse-norge/ 2019-08-23T07:50:27+00:00 https://www.lmi.no/2019/08/23/gar-fram-som-et-stort-forbilde-det-som-er-gjort-her-blir-lagt-merke-til-i-europa/ 2019-08-23T07:59:04+00:00 https://www.lmi.no/2019/08/23/slik-vil-fremtidens-helsetjenester-formes-av-kunstig-intelligens/ 2019-08-23T08:01:43+00:00 https://www.lmi.no/2019/08/23/viagra-blir-reseptfritt-og-truleg-dyrare/ 2019-08-23T08:03:17+00:00 https://www.lmi.no/2019/08/23/amerikansk-legemiddelgigant-kjoper-medisin-utviklet-av-tromsofirma-kan-bli-medisinsalg-for-over-1-milliard-dollar/ 2019-08-23T08:05:06+00:00 https://www.lmi.no/2019/08/23/bemerket-seg-under-aqua-nor/ 2019-08-23T08:33:14+00:00 https://www.lmi.no/wp-content/uploads/2019/08/file6-12.jpeg https://www.lmi.no/wp-content/uploads/2019/08/file2-26.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Bench.jpg https://www.lmi.no/wp-content/uploads/2019/08/panel.jpeg https://www.lmi.no/2019/08/26/vil-fjerne-tak-pa-apotekkjeders-storrelse/ 2019-08-26T07:40:12+00:00 https://www.lmi.no/2019/08/26/etikk-forskere-staten-bor-overta-behandling-fra-det-private-pa-en-betingelse/ 2019-08-26T07:42:27+00:00 https://www.lmi.no/2019/08/26/sverige-satser-videre-pa-rensing-av-legemidler/ 2019-08-26T07:44:02+00:00 https://www.lmi.no/2019/08/26/skal-diskutere-helsetilsynets-vurdering/ 2019-08-26T07:45:56+00:00 https://www.lmi.no/2019/08/26/viagra-blir-reseptfri-fra-nyttar/ 2019-08-26T07:48:10+00:00 https://www.lmi.no/2019/08/26/na-er-vistin-pharmas-100-millionersinvestering-klar-til-styrebehandling/ 2019-08-26T07:55:53+00:00 https://www.lmi.no/2019/08/26/industriens-venn/ 2019-08-26T08:06:41+00:00 https://www.lmi.no/2019/08/26/vil-at-staten-betaler-for-dyr-medisin/ 2019-08-26T08:09:04+00:00 https://www.lmi.no/2019/08/26/blir-lagt-merke-til-i-europa/ 2019-08-26T08:10:48+00:00 https://www.lmi.no/2019/08/26/rhf-ene-nei-til-egenfinansiert-behandling-ja-til-diagnostikk/ 2019-08-26T10:46:43+00:00 https://www.lmi.no/2019/08/27/saker-fra-dm-pharma-4/ 2019-08-27T09:04:13+00:00 https://www.lmi.no/2019/08/27/beslutningsforum-ja-til-flere-nye-behandlinger/ 2019-08-27T09:06:04+00:00 https://www.lmi.no/2019/08/27/gront-lys-for-ny-behandling-av-foflekk-kreft/ 2019-08-27T09:07:38+00:00 https://www.lmi.no/2019/08/27/legemiddelgigant-domt-til-milliardbot/ 2019-08-27T09:09:05+00:00 https://www.lmi.no/2019/08/27/amgen-kjoper-psoriasis-legemiddel-for-120-mrd/ 2019-08-27T09:13:00+00:00 https://www.lmi.no/2019/08/27/inspire-hva-med-senvirkninger-og-overlevernes-helse-og-livskvalitet/ 2019-08-27T09:14:55+00:00 https://www.lmi.no/2019/08/28/opiodikrisen-vi-har-god-kontroll-i-norge/ 2019-08-28T08:14:36+00:00 https://www.lmi.no/2019/08/28/uit-rektor-kan-bli-rik-pa-forskning/ 2019-08-28T08:16:37+00:00 https://www.lmi.no/2019/08/28/kan-ikke-konkludere-entydig-om-ms-medisin/ 2019-08-28T08:18:07+00:00 https://www.lmi.no/2019/08/28/cecilie-daae-ny-sjef-i-helse-nord/ 2019-08-28T08:20:52+00:00 https://www.lmi.no/2019/08/28/tilsyn-leger-opplever-press-om-a-forskrive-vanedannende-legemidler/ 2019-08-28T08:23:52+00:00 https://www.lmi.no/2019/08/28/nebbdyrets-melk-gir-nytt-vapen-mot-bakterier/ 2019-08-28T08:25:56+00:00 https://www.lmi.no/2019/08/28/alt-du-ma-vite-om-viagra/ 2019-08-28T08:28:26+00:00 https://www.lmi.no/2019/08/28/satsar-pa-fullsett-forskingskonferanse/ 2019-08-28T08:30:36+00:00 https://www.lmi.no/2019/08/28/kreftpasienter-faller-inn-under-samme-regelverk-som-oppdrettslaks/ 2019-08-28T08:32:06+00:00 https://www.lmi.no/2019/08/28/rydd-opp-i-regelverket-norske-pasienter-bor-fa-genterapi/ 2019-08-28T08:34:40+00:00 https://www.lmi.no/2019/08/29/oppsummering-av-lmis-styremote-28-august/ 2019-08-29T08:47:11+00:00 https://www.lmi.no/wp-content/uploads/2019/08/styrem%C3%B8te28.aug_.jpg https://www.lmi.no/2019/08/29/fra-dm-pharma-11/ 2019-08-29T09:10:35+00:00 https://www.lmi.no/2019/08/29/vistin-pharmas-kontroversielle-oljeveddemal-gar-enda-litt-darligere-enn-for/ 2019-08-29T09:17:17+00:00 https://www.lmi.no/2019/08/29/industriens-problematisering-av-en-todelt-helsetjeneste/ 2019-08-29T09:19:29+00:00 https://www.lmi.no/2019/08/29/hjelperen-ble-morderen/ 2019-08-29T09:21:27+00:00 https://www.lmi.no/2019/08/29/farmaceutene-vil-gjore-enda-klokere-valg/ 2019-08-29T09:33:34+00:00 https://www.lmi.no/2019/08/29/historisk-forste-legemiddelanskaffelse-med-miljokriterier-gjennomfort/ 2019-08-29T09:37:39+00:00 https://www.lmi.no/2019/08/29/kritisk-til-undersokelse-av-bivirkninger/ 2019-08-29T09:39:06+00:00 https://www.lmi.no/2019/08/29/ms-rapport-resultatet-er-som-forventet/ 2019-08-29T09:40:36+00:00 https://www.lmi.no/2019/08/29/uttrykket-medisinsk-cannabis-er-utdatert/ 2019-08-29T09:42:28+00:00 https://www.lmi.no/2019/08/29/kreftstudie-satt-pa-vent-absurd-situasjon/ 2019-08-29T09:44:17+00:00 https://www.lmi.no/2019/08/29/invitasjon-til-innspill-om-hta/ 2019-08-29T10:07:46+00:00 https://www.lmi.no/2019/08/29/drug-safety-forum-2/ 2019-08-29T12:27:18+00:00 https://www.lmi.no/2019/08/30/hor-katrine-bryne-i-kreftpodden/ 2019-08-30T08:26:08+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Katrine-i-podkaststudio-1.png https://www.lmi.no/wp-content/uploads/2019/08/Katrine-i-podkaststudio-1.png https://www.lmi.no/2019/08/30/skeptisk-til-rangering-av-ms-legemidlene/ 2019-08-30T08:57:10+00:00 https://www.lmi.no/2019/08/30/off-label-anbefalinger-av-okonomiske-hensyn-undergraver-prosesser/ 2019-08-30T08:59:02+00:00 https://www.lmi.no/2019/08/30/oversender-soknad-om-kreftstudie-til-helsedirektoratet/ 2019-08-30T09:00:26+00:00 https://www.lmi.no/2019/08/30/inn-med-baerekraftige-tiltak-mot-legemiddelmangel/ 2019-08-30T09:01:51+00:00 https://www.lmi.no/2019/08/30/over-ni-av-ti-nordmenn-vil-gi-helseopplysninger-til-utvikling-av-bedre-medisiner/ 2019-08-30T09:03:15+00:00 https://www.lmi.no/2019/08/30/ny-plattform-for-helseopplysninger-skal-gi-sikrere-og-raskere-forskning/ 2019-08-30T09:05:42+00:00 https://www.lmi.no/2019/08/30/bare-fortsett-du-store/ 2019-08-30T17:24:44+00:00 https://www.lmi.no/wp-content/uploads/2017/01/Karita_portrett.jpg https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/2019/09/02/forslag-til-endringer-i-bioteknologiloven/ 2019-09-02T08:07:48+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/09/02/immunterapi-gjelder-prinsippet-om-likeverd-bare-for-okonomi/ 2019-09-02T09:52:33+00:00 https://www.lmi.no/2019/09/02/helsetilsynet-etterlater-seg-ryddejobb/ 2019-09-02T09:54:43+00:00 https://www.lmi.no/2019/09/02/trening-kan-bade-forebygge-og-bremse-flere-kreftformer-ifolge-amerikanske-forskere/ 2019-09-02T09:56:17+00:00 https://www.lmi.no/2019/09/02/pci-biotech-selskapet-bruker-lys-i-behandling-av-kreft/ 2019-09-02T09:57:58+00:00 https://www.lmi.no/2019/09/02/off-label-overdrevet-frykt-for-et-urettferdig-helsevesen/ 2019-09-02T09:59:24+00:00 https://www.lmi.no/2019/09/02/helseministeren-vil-forhindre-opioid-epidemi/ 2019-09-02T10:01:22+00:00 https://www.lmi.no/2019/09/02/skeptisk-til-vaksiner/ 2019-09-02T10:06:36+00:00 https://www.lmi.no/2019/09/02/pasientens-opplevelse-sentralt-i-fremtidens-kreftregistrering/ 2019-09-02T10:08:12+00:00 https://www.lmi.no/2019/09/02/urovekkende-at-ikke-flere-er-koblet-pa-systemet/ 2019-09-02T10:09:53+00:00 https://www.lmi.no/2019/09/02/ny-studie-d-vitamin-oker-sjansen-for-a-overleve-kreft/ 2019-09-02T10:25:23+00:00 https://www.lmi.no/2019/09/02/salgstall-fra-farmastat-for-august-2019/ 2019-09-02T12:42:48+00:00 https://www.lmi.no/2019/09/03/frokostmote-om-soknad-til-helsedata-en-praktisk-tilnaerming/ 2019-09-03T06:53:43+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Helsedata-kliniske-studier_org.jpg https://www.lmi.no/2019/09/03/snur-om-kreftstudie/ 2019-09-03T09:05:55+00:00 https://www.lmi.no/2019/09/03/mangel-pa-aurorix-150-mg-og-300-mg-tabletter/ 2019-09-03T09:07:26+00:00 https://www.lmi.no/2019/09/03/industriens-problematisering-av-en-todelt-helsetjeneste-2/ 2019-09-03T09:09:12+00:00 https://www.lmi.no/2019/09/03/en-game-changer-i-behandling-av-hjertesvikt/ 2019-09-03T09:11:00+00:00 https://www.lmi.no/2019/09/03/ny-behandling-mot-hjertesvikt/ 2019-09-03T09:12:40+00:00 https://www.lmi.no/2019/09/03/horing-bekjempelsesplan-for-pankreassykdom/ 2019-09-03T09:35:05+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_STOR.png https://www.lmi.no/2019/09/04/plassering-av-smitteisolasjonsenheter-pa-gaustad-er-en-risiko/ 2019-09-04T09:07:33+00:00 https://www.lmi.no/2019/09/04/sa-enkelt-fikk-johannes-92-kuttet-halvparten-av-medisinene-han-gikk-pa/ 2019-09-04T09:09:38+00:00 https://www.lmi.no/2019/09/04/kampen-fortsetter/ 2019-09-04T09:14:04+00:00 https://www.lmi.no/2019/09/04/toppe-sp-iktyose-pasientene-blir-ikke-sett-og-hort-og-de-har-det-veldig-krevende/ 2019-09-04T09:17:15+00:00 https://www.lmi.no/2019/09/04/hoie-bor-fjerne-hinder-for-nyvinninger-i-helse/ 2019-09-04T09:18:52+00:00 https://www.lmi.no/2019/09/04/innlegg-vi-vil-dele-helsedata/ 2019-09-04T09:20:22+00:00 https://www.lmi.no/2019/09/04/20-kreftpasienter-kan-delta-i-studie-likevel/ 2019-09-04T09:22:53+00:00 https://www.lmi.no/2019/09/02/lmi-vertskap-for-nordisk-konferanse-om-kliniske-studier/ 2019-09-04T09:35:12+00:00 https://www.lmi.no/wp-content/uploads/2019/09/nordic-conference.jpg https://www.lmi.no/wp-content/uploads/2019/09/clinical-trials.jpg https://www.lmi.no/2019/09/04/endringer-i-farmastat/ 2019-09-04T13:13:32+00:00 https://www.lmi.no/wp-content/uploads/2017/02/Tommy-Hille.jpg https://www.lmi.no/wp-content/uploads/2017/02/Tommy-Hille.jpg https://www.lmi.no/2019/09/05/lukt-immunforsvar-og-analyser-dette-har-kommet-ut-av-lakselussenteret/ 2019-09-05T08:55:32+00:00 https://www.lmi.no/2019/09/05/antistoffer-kan-gi-ny-hiv-medisin/ 2019-09-05T09:00:00+00:00 https://www.lmi.no/2019/09/05/ny-pasient-har-fatt-behandling-etter-helsetilsynets-vedtak/ 2019-09-05T09:01:40+00:00 https://www.lmi.no/2019/09/05/medlemsmote-om-digital-markedsforing-av-otc/ 2019-09-05T10:16:08+00:00 https://www.lmi.no/wp-content/uploads/2019/06/OTC-digitale-medier.jpg https://www.lmi.no/2019/09/06/ta-tak-i-genomforskningen/ 2019-09-06T08:29:53+00:00 https://www.lmi.no/2019/09/06/uklar-informasjon-om-bruk-av-deksametason-ved-behandling-med-blincyto-hos-barn/ 2019-09-06T08:31:51+00:00 https://www.lmi.no/2019/09/06/ms-syke-danguole-har-tatt-alle-turmalene-motivasjon-konkurranseinstinkt-og-ny-medisin-har-hjulpet-meg/ 2019-09-06T08:34:59+00:00 https://www.lmi.no/2019/09/06/dyp-laering-kan-erstatte-dyre-objekter-hos-novo-nordisk-krever-innlogging/ 2019-09-06T08:37:08+00:00 https://www.lmi.no/2019/09/06/her-skal-fremtidens-leger-laere-mer-om-a-kutte-medisiner/ 2019-09-06T08:38:57+00:00 https://www.lmi.no/2019/09/06/herlof-nilssen-gar-av-som-helse-vest-direktor/ 2019-09-06T08:41:43+00:00 https://www.lmi.no/2019/09/06/migrene-tar-ikke-ferie/ 2019-09-06T08:43:42+00:00 https://www.lmi.no/2019/09/04/horing-av-forslag-til-endringer-i-helsepersonelloven/ 2019-09-06T11:42:29+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_STOR.png https://www.lmi.no/2019/09/06/kickstartet-innspillsrunde/ 2019-09-06T11:46:36+00:00 https://www.lmi.no/wp-content/uploads/2019/09/hod-2.jpg https://www.lmi.no/wp-content/uploads/2019/09/hod-1.jpg https://www.lmi.no/2019/09/09/the-4th-nordic-rwe-conference-2020/ 2019-09-09T12:01:12+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Helsedata-kliniske-studier_org.jpg https://www.lmi.no/2019/09/10/ledig-plass-i-lmis-pasientutvalg/ 2019-09-10T08:02:24+00:00 https://www.lmi.no/wp-content/uploads/2017/07/utvalgillustrasjon.jpg https://www.lmi.no/2019/09/10/satser-internasjonalt-med-ny-lokal-okonomiansvarlig/ 2019-09-10T08:07:18+00:00 https://www.lmi.no/2019/09/10/pharma-bransjen-darligere-ansett-enn-noensinne-i-usa-lmi-kommenterer/ 2019-09-10T08:12:12+00:00 https://www.lmi.no/2019/09/10/forste-halvar-2019-salget-av-nesespray-oker-fortsatt/ 2019-09-10T08:14:33+00:00 https://www.lmi.no/2019/09/10/todelt-helsetjeneste-kan-forebygges/ 2019-09-10T08:16:05+00:00 https://www.lmi.no/2019/08/05/medietreningskurs/ 2019-09-10T11:37:51+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Media-m%C3%B8te-LMI-H%C3%B8st-2019-1.jpg https://www.lmi.no/wp-content/uploads/2019/06/Media-m%C3%B8te-LMI-H%C3%B8st-2019-1.jpg https://www.lmi.no/2019/08/23/meld-deg-pa-medietrening/ 2019-09-10T11:39:47+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Media-m%C3%B8te-LMI-H%C3%B8st-2019-1.jpg https://www.lmi.no/wp-content/uploads/2019/06/Media-m%C3%B8te-LMI-H%C3%B8st-2019-1.jpg https://www.lmi.no/2019/09/11/horing-forslag-til-endringer-i-lua-ordningen/ 2019-09-11T09:53:00+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/09/11/mer-penger-til-norcrin/ 2019-09-11T10:06:00+00:00 https://www.lmi.no/2019/09/11/godt-nok-for-hvem-slordahl/ 2019-09-11T10:07:24+00:00 https://www.lmi.no/2019/09/12/katrine-bryne-slutter-i-lmi/ 2019-09-12T07:14:40+00:00 https://www.lmi.no/wp-content/uploads/2019/09/katrine2.jpg https://www.lmi.no/wp-content/uploads/2019/09/katrine2.jpg https://www.lmi.no/2019/09/10/hunt-og-lmi-etablerer-arbeidsgruppe-om-bruk-av-helsedata/ 2019-09-12T07:55:48+00:00 https://www.lmi.no/wp-content/uploads/2019/09/file1-34.jpeg https://www.lmi.no/wp-content/uploads/2019/09/Karitabedrefarger.jpeg https://www.lmi.no/2019/09/13/kurs-i-capa-og-root-cause-analyse/ 2019-09-13T07:24:16+00:00 https://www.lmi.no/2019/09/13/skal-lotteritilsynet-ivareta-det-offentliges-ansvar-for-kreftpasienter/ 2019-09-13T07:27:25+00:00 https://www.lmi.no/2019/09/13/norsk-studie-pa-wear-off-symptomer-hos-ms-pasienter/ 2019-09-13T07:29:06+00:00 https://www.lmi.no/2019/09/13/norway-for-life-science-lmi-kommenterer/ 2019-09-13T09:31:51+00:00 https://www.lmi.no/2019/09/13/synliggjor-norsk-livsvitenskap/ 2019-09-13T12:02:29+00:00 https://www.lmi.no/wp-content/uploads/2019/09/file-78.jpeg https://www.lmi.no/wp-content/uploads/2019/09/file-78.jpeg https://www.lmi.no/wp-content/uploads/2019/09/file3-21.jpeg https://www.lmi.no/wp-content/uploads/2019/09/file4-19.jpeg https://www.lmi.no/2019/09/16/offentlige-anskaffelser-28-mai-2019/ 2019-09-16T09:13:47+00:00 https://www.lmi.no/2019/09/16/legemiddelfirmaet-bak-oxycontin-ber-om-konkursbeskyttelse/ 2019-09-16T09:17:57+00:00 https://www.lmi.no/2019/09/16/50-000-konsultasjoner-i-aret-ved-ny-klinikk/ 2019-09-16T09:54:02+00:00 https://www.lmi.no/2019/09/16/det-norske-helseteknologiselskapet-health-tech-skifter-navn/ 2019-09-16T09:55:47+00:00 https://www.lmi.no/2019/09/16/hvordan-bygger-vi-gode-forskningsmiljoer-i-klinikken/ 2019-09-16T10:05:13+00:00 https://www.lmi.no/2019/09/16/forskere-med-en-visjon-om-en-vaksine-for-alt-livet-ut/ 2019-09-16T10:06:48+00:00 https://www.lmi.no/2019/09/16/flere-vaksinerte-fisk-enn-noen-augustmaned-de-seneste-arene/ 2019-09-16T10:08:06+00:00 https://www.lmi.no/2019/09/09/helsedata-kapasitetsproblemer-men-ogsa-et-felt-i-stor-utvikling/ 2019-09-16T11:06:01+00:00 https://www.lmi.no/wp-content/uploads/2019/09/IMG_2981.jpg https://www.lmi.no/wp-content/uploads/2019/09/IMG_2981.jpg https://www.lmi.no/2019/09/16/fabrikken-som-lindrer-smerte/ 2019-09-16T13:09:49+00:00 https://www.lmi.no/wp-content/uploads/2019/09/tpi2.jpg https://www.lmi.no/wp-content/uploads/2019/09/IMG_2477.jpg https://www.lmi.no/wp-content/uploads/2019/09/IMG_2494.jpg https://www.lmi.no/wp-content/uploads/2019/09/tpi2.jpg https://www.lmi.no/2019/09/17/oystein-blir-ny-sjef-i-lovende-kreftforskningsselskap/ 2019-09-17T09:07:27+00:00 https://www.lmi.no/2019/09/17/dette-kommer-pa-arets-easd/ 2019-09-17T09:08:50+00:00 https://www.lmi.no/2019/09/17/todelt-helsetjeneste/ 2019-09-17T09:09:57+00:00 https://www.lmi.no/2019/09/17/en-halvtimes-innsats-fra-deg-kan-gi-mange-mennesker-et-bedre-liv/ 2019-09-17T09:56:21+00:00 https://www.lmi.no/2019/09/17/ny-veiledning-for-markedsforing-av-otc-legemidler/ 2019-09-17T10:40:38+00:00 https://www.lmi.no/wp-content/uploads/2019/09/DSC_8435-e1568704152696.jpg https://www.lmi.no/wp-content/uploads/2019/09/logo2.png https://www.lmi.no/wp-content/uploads/2019/09/DSC_8435-e1568704152696.jpg https://www.lmi.no/wp-content/uploads/2019/09/Eye-tracking.png https://www.lmi.no/2019/09/17/kliniske-studier-ma-bli-integrert-del-av-pasientbehandlingen/ 2019-09-17T12:29:39+00:00 https://www.lmi.no/wp-content/uploads/2019/09/Inspill_KS_HOD-1-e1568723285122.jpg https://www.lmi.no/wp-content/uploads/2019/09/Inspill_KS_HOD.jpg https://www.lmi.no/2019/09/17/referat-5-september-2019/ 2019-09-17T13:43:32+00:00 https://www.lmi.no/2019/09/18/nye-tall-helsekoene-oker-og-pasienter-venter-lenger/ 2019-09-18T08:37:22+00:00 https://www.lmi.no/2019/09/18/uenighet-om-metformin-som-forstevalg/ 2019-09-18T08:39:38+00:00 https://www.lmi.no/2019/09/18/ny-tablett-kan-bety-at-diabetikere-slipper-sproyter/ 2019-09-18T08:41:00+00:00 https://www.lmi.no/2019/09/18/blodsukkersenkende-medisin-reduserer-nyresykdom/ 2019-09-18T08:42:25+00:00 https://www.lmi.no/2019/09/18/kathrine-betaler-5400-kroner-i-maneden-for-migrenemedisin/ 2019-09-18T09:10:55+00:00 https://www.lmi.no/2019/09/18/viktige-temaer-pa-easd/ 2019-09-18T11:18:53+00:00 https://www.lmi.no/wp-content/uploads/2019/09/intervju.jpeg https://www.lmi.no/2019/09/19/fa-folger-radet-om-pafylling-av-barnevaksiner/ 2019-09-19T09:03:01+00:00 https://www.lmi.no/2019/09/19/medisinmangelen-har-aldri-vaert-storre-650-000-nordmenn-kan-bli-rammet/ 2019-09-19T09:04:08+00:00 https://www.lmi.no/2019/09/19/41650/ 2019-09-19T09:08:18+00:00 https://www.lmi.no/2019/09/19/mangel-pa-legemiddel-for-blodtrykk/ 2019-09-19T09:10:39+00:00 https://www.lmi.no/2019/09/19/enklere-liv-for-diabetikere-lmi-kommenterer/ 2019-09-19T09:12:19+00:00 https://www.lmi.no/2019/09/19/la-frem-hunt-data-pa-lungekreft-kongress/ 2019-09-19T09:13:41+00:00 https://www.lmi.no/2019/09/19/referat-23-august/ 2019-09-19T10:34:47+00:00 https://www.lmi.no/2019/07/01/referat-utvalgsmote-i-utvalget-for-sjeldne-sykdommer/ 2019-09-19T10:37:12+00:00 https://www.lmi.no/wp-content/uploads/2017/03/sjeldne-sykdommer_mindre_DIG.png https://www.lmi.no/2019/09/19/frokostmote-om-helsedata/ 2019-09-19T12:13:17+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Helsedata-kliniske-studier_org.jpg https://www.lmi.no/2019/02/01/ytterligere-nedgang-i-kliniske-studier/ 2019-09-19T12:53:20+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Forsidetestfarge_liten-e1566458805776.png https://www.lmi.no/wp-content/uploads/2019/09/Nedgang-studier.png https://www.lmi.no/wp-content/uploads/2019/09/Ikkekommersstudier.png https://www.lmi.no/2019/02/01/storste-selskaper-og-legemiddelsalg/ 2019-09-19T12:53:25+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Forsidetestfarge_liten-e1566458805776.png https://www.lmi.no/wp-content/uploads/2019/09/Selskaper-liste.png https://www.lmi.no/wp-content/uploads/2019/09/omsetning.png https://www.lmi.no/wp-content/uploads/2019/09/produkter.png https://www.lmi.no/wp-content/uploads/2019/09/offentlige-utgifter.png https://www.lmi.no/2019/09/20/fresenius-kabi-best/ 2019-09-20T09:16:31+00:00 https://www.lmi.no/2019/09/20/slik-oppsummerer-norske-eksperter-arets-easd-kongress/ 2019-09-20T09:18:57+00:00 https://www.lmi.no/2019/09/20/ny-rapport-antibiotikabruken-gar-ned/ 2019-09-20T09:20:52+00:00 https://www.lmi.no/2019/09/20/carolina-lik-dodelighet-for-blodsukker-senkende-medisiner/ 2019-09-20T09:24:11+00:00 https://www.lmi.no/2019/09/20/mangel-pa-ranitidin-holdige-legemidler/ 2019-09-20T09:25:56+00:00 https://www.lmi.no/2019/09/20/ny-behandling-gir-hap-til-pasienter-med-uhelbredelig-eggstokkreft-storste-som-har-skjedd-siden-immunterapi/ 2019-09-20T09:27:44+00:00 https://www.lmi.no/2019/09/23/nye-legemidler-er-ofte-ikke-bedre/ 2019-09-23T09:51:16+00:00 https://www.lmi.no/2019/09/23/antibiotikaresistens-i-norge-oppsummert-i-to-setninger/ 2019-09-23T09:52:47+00:00 https://www.lmi.no/2019/09/23/regjeringen-sier-nei-camilla-ma-fortsatt-betale-for-migrenemedisin/ 2019-09-23T09:54:12+00:00 https://www.lmi.no/2019/09/23/fra-glukosesenkende-effekt-av-legemidler-til-organproteksjon/ 2019-09-23T09:55:38+00:00 https://www.lmi.no/2019/09/23/ny-behandling-mot-eggstokkreft-storste-som-har-skjedd-siden-immunterapi/ 2019-09-23T09:56:59+00:00 https://www.lmi.no/2019/09/23/fhi-nedgang-i-antibiotikabruk/ 2019-09-23T09:58:31+00:00 https://www.lmi.no/2019/09/23/apotekene-hadde-rakettvekst-na-har-bransjen-stoppet-opp/ 2019-09-23T10:00:06+00:00 https://www.lmi.no/2019/09/23/utvikler-nytt-lakselusemiddel/ 2019-09-23T10:01:37+00:00 https://www.lmi.no/2019/09/23/gransker-legemidler-etter-funn-av-kreftfremkallende-stoff/ 2019-09-23T10:03:12+00:00 https://www.lmi.no/2019/09/23/fant-flere-lovbrudd-i-hjemmetjenesten/ 2019-09-23T10:38:26+00:00 https://www.lmi.no/2019/09/23/na-skal-malariavaksine-redde-liv/ 2019-09-23T10:39:59+00:00 https://www.lmi.no/2019/09/24/apotekenes-tiltak-mot-legemiddelmangel-godt-mottatt-av-helseministeren/ 2019-09-24T08:25:45+00:00 https://www.lmi.no/2019/09/24/vil-jobbe-for-samarbeid-om-persontilpasset-medisin/ 2019-09-24T08:27:21+00:00 https://www.lmi.no/2019/09/24/nytt-om-legemidler/ 2019-09-24T08:30:32+00:00 https://www.lmi.no/2019/09/24/dette-kan-vaere-arsaken-til-at-babyen-din-grater/ 2019-09-24T08:31:48+00:00 https://www.lmi.no/2019/09/24/ni-nye-metoder-innfores/ 2019-09-24T08:33:22+00:00 https://www.lmi.no/2019/09/24/sier-nei-til-ny-genterapi-for-b-cellelymfom/ 2019-09-24T08:34:46+00:00 https://www.lmi.no/2019/09/24/fordi-det-er-flaut/ 2019-09-24T08:36:25+00:00 https://www.lmi.no/2019/09/24/dette-er-persontilpasset-medisin/ 2019-09-24T08:38:15+00:00 https://www.lmi.no/2019/09/24/biologiske-legemidler/ 2019-09-24T08:42:29+00:00 https://www.lmi.no/2019/09/24/riktig-bruk-av-naloksonnesespray/ 2019-09-24T09:31:56+00:00 https://www.lmi.no/2019/09/24/vil-ha-billigere-migrenemedisin/ 2019-09-24T09:34:03+00:00 https://www.lmi.no/2019/09/24/masse-nye-legemidler-til-ingen-nytte/ 2019-09-25T07:09:23+00:00 https://www.lmi.no/wp-content/uploads/2019/09/Medisiner.jpeg https://www.lmi.no/wp-content/uploads/2019/09/Medisiner.jpeg https://www.lmi.no/2019/09/25/vi-har-ikke-tid-til-a-vente-pa-losninger/ 2019-09-25T10:03:16+00:00 https://www.lmi.no/2019/09/25/ny-rapport-et-dodelig-influensavirus-kan-pa-bare-36-timer-spre-seg-globalt-og-drepe-80-millioner-mennesker/ 2019-09-25T10:05:43+00:00 https://www.lmi.no/2019/09/25/medisin-bare-for-de-rike/ 2019-09-25T10:08:02+00:00 https://www.lmi.no/2019/09/25/skuffet-over-car-t-avgjorelsen/ 2019-09-25T10:09:48+00:00 https://www.lmi.no/2019/09/25/denne-lille-plassen-bidrar-til-a-redde-liv-hver-eneste-dag/ 2019-09-25T10:11:23+00:00 https://www.lmi.no/2019/09/25/sporsmal-til-hoie-om-migrenemedisiner/ 2019-09-25T10:17:23+00:00 https://www.lmi.no/2019/09/25/hoie-onsker-konkurranse-pa-migrenemedisiner/ 2019-09-25T10:18:51+00:00 https://www.lmi.no/2019/09/25/digitale-losninger-ma-tas-i-bruk-i-kliniske-studier/ 2019-09-25T10:20:54+00:00 https://www.lmi.no/2019/09/26/bla-resept-er-urettferdig-og-sann-ma-det-vaere/ 2019-09-26T08:47:19+00:00 https://www.lmi.no/2019/09/26/brexit-skaper-usikkerhet-i-hele-farmasibransjen/ 2019-09-26T08:48:56+00:00 https://www.lmi.no/2019/09/26/ny-behandling-av-insomni-hos-barn-med-asd/ 2019-09-26T08:50:47+00:00 https://www.lmi.no/2019/09/26/nye-muligheter-i-ms-behandling/ 2019-09-26T08:52:45+00:00 https://www.lmi.no/2019/09/26/roche-topp-om-persontilpasset-medisin/ 2019-09-26T08:54:48+00:00 https://www.lmi.no/2019/09/26/microsoft-skal-samarbeide-med-astrazeneca-om-ai-inkubator/ 2019-09-26T08:58:17+00:00 https://www.lmi.no/2019/09/26/forste-eu-godkjente-legemiddel-med-tumoragnostisk-indikasjon/ 2019-09-26T08:59:33+00:00 https://www.lmi.no/2019/09/26/workshop-bransjereglene/ 2019-09-26T11:24:03+00:00 https://www.lmi.no/wp-content/uploads/2019/05/Bransjeregler-2020.jpg https://www.lmi.no/2019/09/26/ikke-klokere-om-ms-behandling/ 2019-09-26T19:04:18+00:00 https://www.lmi.no/wp-content/uploads/2019/09/line-dm-arena.jpg https://www.lmi.no/wp-content/uploads/2019/09/line-dm-arena.jpg https://www.lmi.no/wp-content/uploads/2019/09/celius.jpg https://www.lmi.no/2016/10/11/info-emas-styremote-oktober/ 2019-09-27T09:19:14+00:00 https://www.lmi.no/2019/09/27/nye-medikamenter-ma-ha-dokumentert-effekt/ 2019-09-27T10:39:54+00:00 https://www.lmi.no/2019/09/27/mange-menn-vet-ikke-at-de-kan-fa-brystkreft/ 2019-09-27T10:41:50+00:00 https://www.lmi.no/2019/09/27/gar-tom-for-behandling/ 2019-09-27T10:43:42+00:00 https://www.lmi.no/2019/09/27/fremtidens-kreftbehandling-er-persontilpasset-men-det-haster-med-a-fa-pa-plass-losninger/ 2019-09-27T10:45:17+00:00 https://www.lmi.no/2019/09/27/beslutningsforum-sa-nei-til-to-nye-genterapier-til-voksne-med-lymfekreft/ 2019-09-27T10:48:33+00:00 https://www.lmi.no/2019/09/27/na-kommer-en-ny-effektiv-medisin-mot-psoriasis/ 2019-09-27T10:50:16+00:00 https://www.lmi.no/2019/09/27/brenner-for-diabetes-saken/ 2019-09-27T10:51:29+00:00 https://www.lmi.no/2019/09/27/na-far-danske-farmasoyter-skrive-ut-medisiner/ 2019-09-27T10:52:44+00:00 https://www.lmi.no/2019/09/27/vi-har-mulighet-til-a-bygge-noe-nytt-for-nasjonen/ 2019-09-27T13:01:36+00:00 https://www.lmi.no/wp-content/uploads/2019/09/Karita3.jpg https://www.lmi.no/wp-content/uploads/2019/09/Karita3-1.jpg https://www.lmi.no/wp-content/uploads/2019/09/Lofthus.jpg https://www.lmi.no/2019/09/30/mer-malrettet-behandling/ 2019-09-30T10:09:00+00:00 https://www.lmi.no/2019/09/30/tonje-20-har-satt-livet-pa-vent-fortviler-etter-tre-avslag-pa-medisin/ 2019-09-30T10:10:19+00:00 https://www.lmi.no/2019/09/30/persontilpasset-medisin-er-et-kjempeskritt-fremover-for-a-bekjempe-sykdom/ 2019-09-30T10:11:54+00:00 https://www.lmi.no/2019/09/30/na-har-kronisk-migrenepasienter-ventet-lenge-nok/ 2019-09-30T10:17:22+00:00 https://www.lmi.no/2019/09/30/kan-slippe-cellegift/ 2019-09-30T10:18:49+00:00 https://www.lmi.no/2019/09/30/vi-trenger-forsvarlighet-i-kreftbehandlingen/ 2019-09-30T10:23:44+00:00 https://www.lmi.no/2019/09/30/aud-67-fikk-brystkreft-for-andre-gang/ 2019-09-30T10:26:23+00:00 https://www.lmi.no/2019/09/30/nye-dyre-medisiner-er-ikke-nodvendigvis-bedre-enn-de-gamle/ 2019-09-30T10:27:38+00:00 https://www.lmi.no/2019/09/30/kjempa-lenge-for-livsviktig-medisin-no-er-spenninga-utloyst/ 2019-09-30T10:28:57+00:00 https://www.lmi.no/2019/09/30/hun-fikk-brystkreft-men-slapp-cellegift/ 2019-09-30T10:34:28+00:00 https://www.lmi.no/2019/09/30/vi-er-skuffet-pa-pasientenes-vegne/ 2019-09-30T10:38:06+00:00 https://www.lmi.no/2019/09/30/hoie-om-persontilpasset-medisin-helsetjenesten-ikke-godt-nok-forberedt/ 2019-09-30T10:39:35+00:00 https://www.lmi.no/2019/09/30/hvorfor-nekter-du-meg-og-25-000-andre-hjelp-bent-hoie/ 2019-09-30T10:41:16+00:00 https://www.lmi.no/2019/09/30/hoie-migrenemedisin-pa-bla-resept/ 2019-09-30T10:43:12+00:00 https://www.lmi.no/2019/09/30/hoies-prioriteringer-gir-hodepine/ 2019-09-30T10:46:33+00:00 https://www.lmi.no/2019/09/30/oppfolgingsbrev-til-hoie-om-legemiddelmangler/ 2019-09-30T11:54:54+00:00 https://www.lmi.no/wp-content/uploads/2017/02/karita_og_erling_dm-bilde.jpg https://www.lmi.no/wp-content/uploads/2017/02/karita_og_erling_dm-bilde.jpg https://www.lmi.no/2019/05/22/referat-6-mai-2019/ 2019-09-30T13:05:04+00:00 https://www.lmi.no/2019/09/30/markedstilgangsutvalget-13-september-2019/ 2019-09-30T13:06:19+00:00 https://www.lmi.no/2019/09/27/mote-pa-haukeland-med-fokus-pa-immunologi-stamcellebehandling-og-kreftmedisin/ 2019-09-30T17:07:20+00:00 https://www.lmi.no/wp-content/uploads/2019/09/ani-kolleshi-684082-unsplash.jpg https://www.lmi.no/2019/10/01/aesgp-euro-otc-news-august-september-2019/ 2019-10-01T07:21:10+00:00 https://www.lmi.no/2019/10/01/oslo-kommune-utreder-obligatorisk-vaksinasjon/ 2019-10-01T09:12:10+00:00 https://www.lmi.no/2019/10/01/mange-bruker-for-mye-smertestillende/ 2019-10-01T09:14:23+00:00 https://www.lmi.no/2019/10/01/milepael-for-norsk-kreftstudie/ 2019-10-01T09:16:04+00:00 https://www.lmi.no/2019/10/01/blodprove-kan-erstatte-biopsi/ 2019-10-01T09:17:38+00:00 https://www.lmi.no/2019/10/01/okning-i-antall-influensavaksinerte/ 2019-10-01T09:19:18+00:00 https://www.lmi.no/2019/10/01/diskuterer-nytt-inspire-prosjekt-i-gangene-pa-esmo/ 2019-10-01T09:20:47+00:00 https://www.lmi.no/2019/10/01/se-hele-fremtidens-kliniske-studier-motet-her/ 2019-10-01T12:48:46+00:00 https://www.lmi.no/wp-content/uploads/2019/09/Lofthus.jpg https://www.lmi.no/2019/10/01/referat-6-september-2019/ 2019-10-01T12:59:12+00:00 https://www.lmi.no/2019/10/01/salgstall-fra-farmastat-for-september-2019/ 2019-10-01T13:13:10+00:00 https://www.lmi.no/2019/10/02/grenselost-forskningssamarbeid/ 2019-10-02T08:37:31+00:00 https://www.lmi.no/2019/10/02/ny-behandling-gir-bedre-overlevelse-for-pasienter-med-langtkommen-melanom/ 2019-10-02T08:40:05+00:00 https://www.lmi.no/2019/10/02/ny-behandling-av-prostatakreft/ 2019-10-02T08:41:53+00:00 https://www.lmi.no/2019/10/02/legemiddelverket-oppdaget-feil-i-reseptsystem-dette-skjer-sjelden/ 2019-10-02T08:45:05+00:00 https://www.lmi.no/2019/10/02/mangler-medisiner/ 2019-10-02T08:51:37+00:00 https://www.lmi.no/2019/10/02/gigantavtaler-til-800-millioner-kroner-gir-50-nye-jobber-pa-curida/ 2019-10-02T08:54:19+00:00 https://www.lmi.no/2017/02/02/slik-ble-fiskehelsearet-2016/ 2019-10-02T12:39:40+00:00 https://www.lmi.no/2017/02/22/nytt-legemidler-nr-4-21-februar/ 2019-10-02T13:18:24+00:00 https://www.lmi.no/2017/02/22/stabilt-butikksalg-reseptfrie-legemidler/ 2019-10-02T13:19:28+00:00 https://www.lmi.no/2019/10/03/nodvendig-helsehjelp-eller-bemidledes-bakvei-inn-i-offentlig-helsetjeneste/ 2019-10-03T08:51:48+00:00 https://www.lmi.no/2019/10/03/medisinmangel-gar-ut-over-pasientsikkerhet-slik-kan-det-ikke-vaere/ 2019-10-03T08:53:39+00:00 https://www.lmi.no/2019/10/03/departementet-ber-legemiddelverket-om-a-starte-prisforhandlinger-pa-migrenemedisin/ 2019-10-03T08:59:37+00:00 https://www.lmi.no/2019/10/03/vi-trenger-en-apen-vaksinedebatt-med-faglige-innspill/ 2019-10-03T09:01:17+00:00 https://www.lmi.no/2019/10/03/forvrenging-av-fakta-hoie/ 2019-10-03T09:04:29+00:00 https://www.lmi.no/2019/10/03/karita-med-innlegg-i-aftenposten/ 2019-10-03T09:08:50+00:00 https://www.lmi.no/2019/10/03/delta-i-lmis-arbeidsgruppe-med-fokus-pa-off-label-bruk/ 2019-10-03T12:39:32+00:00 https://www.lmi.no/wp-content/uploads/2019/10/dylan-gillis-KdeqA3aTnBY-unsplash.jpg https://www.lmi.no/2019/10/04/ett-ar-med-hodepine/ 2019-10-04T09:24:14+00:00 https://www.lmi.no/2019/10/04/israelske-forskere-finner-ny-behandling-mot-beinkreft/ 2019-10-04T09:25:46+00:00 https://www.lmi.no/2019/10/04/tiar-med-smertehelvete-for-bergensk-naeringslivstopp/ 2019-10-04T09:27:22+00:00 https://www.lmi.no/2019/10/04/helseministeren-svarer-jeg-nekter-ingen-hjelp/ 2019-10-04T09:29:15+00:00 https://www.lmi.no/2019/10/04/storbritannia-med-nytt-eksportforbud-brexit-kan-gi-medisinmangel-i-norge/ 2019-10-04T09:33:06+00:00 https://www.lmi.no/2019/10/07/novartis-har-gjort-sin-del-av-jobben-men-ikke-bent-hoie/ 2019-10-07T10:18:17+00:00 https://www.lmi.no/2019/10/07/her-er-helsetallene-i-budsjettet/ 2019-10-07T10:19:48+00:00 https://www.lmi.no/2019/10/07/hoies-prioriteringer-gir-hodepine-2/ 2019-10-07T10:20:35+00:00 https://www.lmi.no/2019/10/07/staten-har-god-kontroll-pa-legemiddelutgiftene-na-men-nye-utfordringer-kommer/ 2019-10-07T10:22:28+00:00 https://www.lmi.no/2019/10/07/tommy-45-har-brukt-enorme-summer-pa-privat-kreftbehandling-det-mener-han-har-berget-livet-sa-langt/ 2019-10-07T10:24:32+00:00 https://www.lmi.no/2019/10/07/flere-menn-tar-hivmedisin/ 2019-10-07T10:27:16+00:00 https://www.lmi.no/2019/10/07/arets-influensavaksine-kommer-neste-uke-16-millioner-nordmenn-bor-ta-den/ 2019-10-07T10:29:14+00:00 https://www.lmi.no/2019/10/07/engelske-myndigheter-sier-nei-til-ny-migrenemedisin/ 2019-10-07T10:31:07+00:00 https://www.lmi.no/2017/06/29/tidenes-storste-narkotikakrise-legen-dealer/ 2019-10-07T11:36:32+00:00 https://www.lmi.no/2019/10/07/styremote-i-lmi-14-oktober/ 2019-10-07T11:53:37+00:00 https://www.lmi.no/wp-content/uploads/2019/03/Styret-2019.jpg https://www.lmi.no/wp-content/uploads/2019/04/Veronika-Barrabes-e1559897653464.jpg https://www.lmi.no/2019/10/07/hold-av-datoene-for-strategisamling-i-november/ 2019-10-07T14:19:49+00:00 https://www.lmi.no/wp-content/uploads/2017/10/St%C3%B8tvig-Hotell.jpeg https://www.lmi.no/wp-content/uploads/2017/10/St%C3%B8tvig-Hotell.jpeg https://www.lmi.no/2019/10/07/hoydepunkter-fra-statsbudsjettet-2/ 2019-10-07T17:32:08+00:00 https://www.lmi.no/wp-content/uploads/2019/10/statsbudsjett-utsnitt.jpg https://www.lmi.no/wp-content/uploads/2019/10/statsbudsjettet-gult.jpg https://www.lmi.no/2019/10/08/det-er-en-ledig-plass-i-lmis-complianceutvalg/ 2019-10-08T07:22:31+00:00 https://www.lmi.no/wp-content/uploads/2017/07/utvalgillustrasjon.jpg https://www.lmi.no/2019/10/08/prep-er-en-suksess-for-folkehelsen-og-staten/ 2019-10-08T09:07:39+00:00 https://www.lmi.no/2019/10/08/hvem-skal-fa-dyre-kreftmedisiner/ 2019-10-08T09:09:55+00:00 https://www.lmi.no/2019/10/08/statsbudsjettet-2020-ingen-satsing-pa-persontilpasset-medisin/ 2019-10-08T09:11:30+00:00 https://www.lmi.no/2019/10/08/statsbudsjettet-apotekene-far-ikke-dekket-utgifter-til-nye-statlige-oppgaver/ 2019-10-08T09:13:13+00:00 https://www.lmi.no/2019/10/08/er-dette-krfs-helsepolitikk/ 2019-10-08T09:15:09+00:00 https://www.lmi.no/2019/10/08/mangel-pa-indivina/ 2019-10-08T09:18:17+00:00 https://www.lmi.no/2019/10/08/beslutningsforums-beslutninger-per-23-september-2019/ 2019-10-08T09:46:25+00:00 https://www.lmi.no/2019/10/08/regjeringen-svikter-migrenepasientene/ 2019-10-08T10:42:15+00:00 https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/2019/10/08/novartis-svarer-om-migrenemedisin-helseministerens-prisbloff/ 2019-10-08T10:46:19+00:00 https://www.lmi.no/2019/10/08/lmi-mener-fullmaktsgrensen-ma-hoynes-krever-innlogging/ 2019-10-08T11:02:10+00:00 https://www.lmi.no/2019/10/08/15-millioner-kroner-til-legemiddelverket-krever-innlogging/ 2019-10-08T11:03:33+00:00 https://www.lmi.no/2019/10/09/hadde-siv-fatt-kreft-en-uke-tidligere-ville-behandlingen-bestatt-av-cellegift-men-sa-fikk-hun-et-sporsmal-som-endret-alt/ 2019-10-09T09:01:38+00:00 https://www.lmi.no/2019/10/09/oppmoda-forskingsmiljoet-til-samhandling/ 2019-10-09T09:04:00+00:00 https://www.lmi.no/2019/10/09/forsinket-vaksine-kan-gi-hektisk-influensasesong/ 2019-10-09T09:05:16+00:00 https://www.lmi.no/2019/10/09/lmi-i-mote-med-naeringsministeren/ 2019-10-09T10:56:50+00:00 https://www.lmi.no/wp-content/uploads/2019/10/1-2.jpg https://www.lmi.no/wp-content/uploads/2019/10/1-2-1.jpg https://www.lmi.no/wp-content/uploads/2019/10/3-2.jpg https://www.lmi.no/2019/10/09/frokostmote-om-helsedata-helseanalyseplattformen/ 2019-10-09T14:13:10+00:00 https://www.lmi.no/wp-content/uploads/2019/10/ML1.jpg https://www.lmi.no/wp-content/uploads/2019/10/2.jpg https://www.lmi.no/2019/10/10/velkommen-til-drug-safety-forum-2/ 2019-10-10T08:05:35+00:00 https://www.lmi.no/2019/10/10/brenner-for-bransjen/ 2019-10-10T08:47:24+00:00 https://www.lmi.no/wp-content/uploads/2019/10/Leger-i-industrien_nicolas.jpg https://www.lmi.no/wp-content/uploads/2019/10/Leger-i-industrien_nicolas.jpg https://www.lmi.no/2019/10/10/ms-starter-off-label-studie/ 2019-10-10T09:20:31+00:00 https://www.lmi.no/2019/10/10/avslag-med-bivirkninger/ 2019-10-10T09:20:45+00:00 https://www.lmi.no/2019/10/10/etterlyser-oppstartmidler-for-kliniske-studier/ 2019-10-10T09:23:03+00:00 https://www.lmi.no/2019/10/10/nytt-prioriteringskriterium/ 2019-10-10T09:25:42+00:00 https://www.lmi.no/2019/10/10/slv-med-i-internasjonalt-metodevarslingsprosjekt-krever-innlogging/ 2019-10-10T09:27:32+00:00 https://www.lmi.no/2019/10/10/jorun-fikk-kreftbehandling-som-virket-trodde-ikke-hun-ville-overleve-sommeren/ 2019-10-10T09:29:33+00:00 https://www.lmi.no/2019/10/10/mer-opptatt-av-monopolmakt-enn-pasientene/ 2019-10-10T09:31:36+00:00 https://www.lmi.no/2019/10/09/industrien-klar-for-stopptober/ 2019-10-10T09:52:51+00:00 https://www.lmi.no/wp-content/uploads/2019/10/stopptoberplakat2.jpg https://www.lmi.no/wp-content/uploads/2019/10/stopptober-fb.jpg https://www.lmi.no/wp-content/uploads/2019/10/stopptoberbutton-og-lege.jpg https://www.lmi.no/2019/10/10/deltok-pa-strategimote-i-brussel/ 2019-10-10T10:31:35+00:00 https://www.lmi.no/wp-content/uploads/2019/10/Brussel.jpg https://www.lmi.no/2019/09/25/referat-20-september-2019/ 2019-10-10T12:47:31+00:00 https://www.lmi.no/2019/10/11/nyansettelser-i-lmi/ 2019-10-11T08:04:05+00:00 https://www.lmi.no/wp-content/uploads/2019/10/Hege_sorthvitt_2.jpg https://www.lmi.no/wp-content/uploads/2019/10/Hege_sorthvitt_2.jpg https://www.lmi.no/wp-content/uploads/2019/10/MarieSAase_.jpg https://www.lmi.no/2019/10/11/immunterapi-saken-vil-ikke-bli-anklaget-for-uforsvarlig-helsehjelp/ 2019-10-11T08:45:06+00:00 https://www.lmi.no/2019/10/11/mindre-antibiotikabruk-i-oppdrett-enn-i-landbruket/ 2019-10-11T08:47:28+00:00 https://www.lmi.no/2019/10/11/the-life-science-cluster-har-blitt-arena-klynge/ 2019-10-11T08:49:10+00:00 https://www.lmi.no/2019/10/11/vil-samle-vaksineinformasjon-om-alle-nordmenn-i-sentralt-register/ 2019-10-11T08:51:01+00:00 https://www.lmi.no/2019/10/14/pasienter-er-ikke-som-oppdrettslaks/ 2019-10-14T09:08:33+00:00 https://www.lmi.no/2019/10/14/svindyr-migrenemedisin/ 2019-10-14T09:13:23+00:00 https://www.lmi.no/2019/10/14/en-kynisk-industri/ 2019-10-14T09:15:11+00:00 https://www.lmi.no/2019/10/14/70-soker-om-a-bli-senter-for-forskningsdrevet-innovasjon/ 2019-10-14T09:16:51+00:00 https://www.lmi.no/2019/10/14/jorun-fikk-kreftbehandling-som-virket-trodde-ikke-hun-ville-overleve-sommeren-2/ 2019-10-14T09:18:29+00:00 https://www.lmi.no/2019/10/14/bekymret-for-ungdoms-bruk-av-smertestillende-medisiner-uheldig-og-farlig/ 2019-10-14T09:20:53+00:00 https://www.lmi.no/2019/10/14/hoies-tvetydighet-skremmer-meg/ 2019-10-14T09:22:39+00:00 https://www.lmi.no/2019/10/14/avslag-med-bivirkninger-2/ 2019-10-14T09:24:48+00:00 https://www.lmi.no/2019/10/14/farmasjef-en-smak-av-ledelse/ 2019-10-14T09:37:43+00:00 https://www.lmi.no/2019/10/14/forum-for-politikerkontakt/ 2019-10-14T10:53:33+00:00 https://www.lmi.no/wp-content/uploads/2017/07/utvalgillustrasjon.jpg https://www.lmi.no/2019/10/15/se-barrabes-oppsummere-lmis-styremote-14-oktober/ 2019-10-15T09:22:20+00:00 https://www.lmi.no/wp-content/uploads/2019/10/Veronika-styrem%C3%B8te.jpg https://www.lmi.no/wp-content/uploads/2019/10/file.jpeg https://www.lmi.no/wp-content/uploads/2019/10/Leif-Rune-styrem%C3%B8te.jpeg https://www.lmi.no/2019/10/16/nyoppdaget-stoff-hindret-ms-symptomer-hos-mus/ 2019-10-16T07:35:20+00:00 https://www.lmi.no/2019/10/16/oppfordrer-til-a-bruke-diabetesmedisin-mot-fedme/ 2019-10-16T07:37:01+00:00 https://www.lmi.no/2019/10/16/kan-det-dokumenteres-at-prep-er-samfunnsokonomisk-lonnsomt/ 2019-10-16T07:38:37+00:00 https://www.lmi.no/2019/10/16/viagra-uten-resept-dette-bor-du-vite-pfizer-kommenterer/ 2019-10-16T07:43:11+00:00 https://www.lmi.no/2019/10/17/starter-off-label-studie/ 2019-10-17T08:54:49+00:00 https://www.lmi.no/2019/10/17/fagmiljoer-med-hard-kritikk-mot-direktoratet-for-e-helse/ 2019-10-17T09:30:13+00:00 https://www.lmi.no/2019/10/17/studie-eldre-far-det-bedre-nar-de-trapper-ned-medisinbruken/ 2019-10-17T09:31:34+00:00 https://www.lmi.no/2019/10/17/etterlyser-oppstart-midler-for-kliniske-studier/ 2019-10-17T09:33:00+00:00 https://www.lmi.no/2019/10/17/hoie-om-brexit-og-parallelleksport/ 2019-10-17T09:48:18+00:00 https://www.lmi.no/wp-content/uploads/2016/09/torsdag-H%C3%B8ie.jpg https://www.lmi.no/wp-content/uploads/2019/10/M%C3%B8rland.jpg https://www.lmi.no/wp-content/uploads/2019/03/hoie2_hoyopploselig-e1553069823244.jpg https://www.lmi.no/2019/10/17/new-clinical-trial-at-oslo-university-hospital/ 2019-10-17T10:20:49+00:00 https://www.lmi.no/2019/10/01/plassering-av-finansieringsansvaret/ 2019-10-17T11:50:45+00:00 https://www.lmi.no/2019/10/14/plassering-av-finansieringsansvar-4/ 2019-10-17T11:51:08+00:00 https://www.lmi.no/2019/10/17/lmi-pa-horing-i-helse-og-omsorgsdepartementet/ 2019-10-17T13:06:00+00:00 https://www.lmi.no/wp-content/uploads/2019/10/eu1.png https://www.lmi.no/wp-content/uploads/2019/10/eu1.png https://www.lmi.no/2019/10/18/nytt-forskningssenter-for-nevrologiske-sykdommer/ 2019-10-18T07:52:16+00:00 https://www.lmi.no/2019/10/18/hva-skal-til-for-a-lage-en-influensavaksine-som-gjor-oss-immune-resten-av-livet/ 2019-10-18T07:53:20+00:00 https://www.lmi.no/2019/10/18/acd-pharma-har-tro-pa-kommersiell-og-medisinsk-suksess-med-bakteriofager/ 2019-10-18T07:54:43+00:00 https://www.lmi.no/2019/10/18/bakteriofager-har-potensial-som-okologisk-og-baerekraftig-legemiddel/ 2019-10-18T07:55:38+00:00 https://www.lmi.no/2019/10/18/utvikling-av-nye-antibiotika-ma-lonne-seg/ 2019-10-18T07:59:46+00:00 https://www.lmi.no/2019/10/18/reagerer-pa-migrenemedisin-nei-ma-finne-en-losning/ 2019-10-18T10:42:55+00:00 https://www.lmi.no/2019/10/21/nordic-nanovector-skal-hente-penger/ 2019-10-21T08:13:07+00:00 https://www.lmi.no/2019/10/21/storbeslag-av-piller-pa-gardermoen/ 2019-10-21T08:14:43+00:00 https://www.lmi.no/2019/10/21/reagerer-pa-migrenemedisin-nei-ma-finne-en-losning-2/ 2019-10-21T08:56:10+00:00 https://www.lmi.no/2019/10/21/norske-forskere-vil-drepe-kreftceller-med-radioaktive-atomer-fra-naturlig-thorium/ 2019-10-21T08:57:41+00:00 https://www.lmi.no/2019/10/21/slik-forsoker-forskere-a-lose-als-gaten/ 2019-10-21T08:59:08+00:00 https://www.lmi.no/2019/10/21/norsk-biovitenskap-og-industri-samles-under-en-hatt/ 2019-10-21T09:02:17+00:00 https://www.lmi.no/2019/10/21/lover-verktoyet-som-skal-gi-fremtidens-antibiotika/ 2019-10-21T09:03:52+00:00 https://www.lmi.no/2019/10/21/ny-studie-sa-sikker-er-antidepressiva/ 2019-10-21T09:05:12+00:00 https://www.lmi.no/2019/10/21/rystende-tall-om-norske-tenaringer/ 2019-10-21T09:06:36+00:00 https://www.lmi.no/2019/10/21/skreddersydd-behandling-gir-hap-for-kreftpasienter/ 2019-10-21T09:07:48+00:00 https://www.lmi.no/2019/10/21/virus-skal-kurere-diabetes/ 2019-10-21T09:09:04+00:00 https://www.lmi.no/2019/10/21/frokostmote-om-helsedata-2/ 2019-10-21T10:59:25+00:00 https://www.lmi.no/wp-content/uploads/2019/06/Helsedata-kliniske-studier_org.jpg https://www.lmi.no/2019/10/21/mote-i-young-pharma-network/ 2019-10-21T13:13:12+00:00 https://www.lmi.no/2019/10/22/pilleselskapene-ma-betale-milliarder-nekter-a-innromme-skyld/ 2019-10-22T07:58:33+00:00 https://www.lmi.no/2019/10/22/ehin-2019-persontilpasset-medisin-og-e-helse-smelter-sammen/ 2019-10-22T08:00:10+00:00 https://www.lmi.no/2019/10/22/gir-149-millioner-kroner-til-multisenter-studier/ 2019-10-22T08:01:45+00:00 https://www.lmi.no/2019/10/22/ny-malrettet-leukemi-behandling-godkjent-av-beslutningsforum/ 2019-10-22T08:04:35+00:00 https://www.lmi.no/2019/10/22/fem-nye-kreftlegemidler-og-norges-forste-genprofiltest/ 2019-10-22T08:55:37+00:00 https://www.lmi.no/2019/10/22/syv-nye-medisiner-anbefales-for-godkjenning-i-eu/ 2019-10-22T08:57:10+00:00 https://www.lmi.no/2019/10/22/etablerer-enhet-for-fremtidens-kreftdiagnostikk/ 2019-10-22T10:53:14+00:00 https://www.lmi.no/2019/10/23/etablerer-enhet-for-fremtidens-kreftdiagnostikk-2/ 2019-10-23T08:39:06+00:00 https://www.lmi.no/2019/10/23/rekordstor-legemiddelmangel-legemiddelindustrien-vil-gi-pasientene-innsyn-i-apotekenes-lagerbeholdning/ 2019-10-23T08:40:39+00:00 https://www.lmi.no/2019/10/23/regjeringen-vil-ha-tiltak-mot-medisinmangel-lmi-kommenterer/ 2019-10-23T08:42:00+00:00 https://www.lmi.no/2019/10/23/karita-bekkemellem-tar-influensavaksine/ 2019-10-23T09:09:55+00:00 https://www.lmi.no/wp-content/uploads/2019/10/vaksine-karita.png https://www.lmi.no/2019/10/23/bred-enighet-pa-persontilpasset-medisin-debatt-vi-trenger-hoyere-tempo/ 2019-10-23T09:19:33+00:00 https://www.lmi.no/wp-content/uploads/2019/10/Line1.jpg https://www.lmi.no/wp-content/uploads/2019/10/Line.jpg https://www.lmi.no/wp-content/uploads/2019/10/h%C3%B8ie.jpg https://www.lmi.no/2019/10/24/dra-forum-inviterer-til-medlemsmote/ 2019-10-24T07:49:14+00:00 https://www.lmi.no/2019/10/24/oppskrift-pa-nedgang-i-kliniske-studier/ 2019-10-24T08:06:04+00:00 https://www.lmi.no/wp-content/uploads/2016/03/Karita-Bekkemellem-Helsen%C3%A6ring-med-stort-potensial.jpg https://www.lmi.no/wp-content/uploads/2019/04/Karita-Bekkemellem.jpg https://www.lmi.no/2019/10/24/dette-ma-du-vite-om-immunterapi/ 2019-10-24T08:13:15+00:00 https://www.lmi.no/2019/10/24/bent-hoies-utalmodighet-hjelper-lite-nar-finansiering-mangler/ 2019-10-24T08:14:37+00:00 https://www.lmi.no/2019/10/24/planlegger-fire-ms-studier/ 2019-10-24T08:18:38+00:00 https://www.lmi.no/2019/10/25/prep-har-bidratt-til-rekordlave-hiv-tall/ 2019-10-25T10:23:19+00:00 https://www.lmi.no/2019/10/25/vi-ma-behandle-pasienten-ikkje-berre-kreftsvulsten/ 2019-10-25T10:25:15+00:00 https://www.lmi.no/2019/10/25/miljovernpris-til-tag-sensors/ 2019-10-25T10:27:16+00:00 https://www.lmi.no/2019/10/25/88-har-mistet-livet-gar-nye-veier-for-a-hindre-feilmedisinering/ 2019-10-25T10:42:19+00:00 https://www.lmi.no/2019/10/25/legemiddelverket-onsker-dialog-om-utfordringer-knyttet-til-brexit/ 2019-10-25T10:43:46+00:00 https://www.lmi.no/2019/10/25/immunterapi-godkjent-for-norske-pasienter-med-trippel-negativ-brystkreft-med-spredning/ 2019-10-25T10:45:54+00:00 https://www.lmi.no/2019/10/25/anders-jahreprisen-til-kreftforsker/ 2019-10-25T10:47:28+00:00 https://www.lmi.no/2019/10/25/ny-forskning-gir-hap-for-migrene-ofre/ 2019-10-25T10:49:57+00:00 https://www.lmi.no/2019/10/25/komplett-apotek-bytter-navn-og-far-ny-toppsjef/ 2019-10-25T10:51:57+00:00 https://www.lmi.no/2019/10/25/farmaceutene-vil-ha-legemidlene-tilbake-til-apotekene/ 2019-10-25T10:53:23+00:00 https://www.lmi.no/2019/10/28/statsradens-privatpraktiserende-politikk/ 2019-10-28T08:22:59+00:00 https://www.lmi.no/2019/10/28/stor-pagang-etter-arets-influensavaksine/ 2019-10-28T10:00:34+00:00 https://www.lmi.no/2019/10/28/na-er-hunt-i-gang/ 2019-10-28T10:02:52+00:00 https://www.lmi.no/2019/10/28/fedmeeksperter-flere-bor-fa-medisiner-mot-fedme-pa-bla-resept/ 2019-10-28T10:04:25+00:00 https://www.lmi.no/2019/10/28/curida-suksessen-er-en-kjempeseier-for-elverum/ 2019-10-28T10:08:25+00:00 https://www.lmi.no/2019/10/28/informasjonsmote-for-industrien-3-desember/ 2019-10-28T10:30:38+00:00 https://www.lmi.no/2019/10/29/10-000-nordmenn-kan-ha-demenssjukdom-som-sjeldan-blir-oppdaga/ 2019-10-29T10:19:35+00:00 https://www.lmi.no/2019/10/29/prisbesettelsen-rammer-oss-alle/ 2019-10-29T10:20:46+00:00 https://www.lmi.no/2019/10/29/en-ekte-brobygger-mellom-helse-og-teknologi/ 2019-10-29T10:22:16+00:00 https://www.lmi.no/2019/10/29/til-helseminister-bent-hoie/ 2019-10-29T10:27:32+00:00 https://www.lmi.no/2019/10/29/haukeland-forst-ute-med-ny-radioaktiv-kreftmedisin/ 2019-10-29T10:28:53+00:00 https://www.lmi.no/2019/10/29/mener-okende-kunnskapsgap-krever-prisdebatt/ 2019-10-29T10:30:09+00:00 https://www.lmi.no/2019/10/29/curida-femdobler-produksjonen/ 2019-10-29T11:32:16+00:00 https://www.lmi.no/wp-content/uploads/2019/10/curida-fabrikkbilde.jpg https://www.lmi.no/wp-content/uploads/2019/10/Leif-Rune-og-Christian.jpg https://www.lmi.no/2019/10/30/biogen-gjor-helomvending-med-alzheimers-legemiddel/ 2019-10-30T10:17:33+00:00 https://www.lmi.no/2019/10/30/planlegger-fire-ms-studier-2/ 2019-10-30T10:19:17+00:00 https://www.lmi.no/2019/10/30/nytt-hap-for-lungekreftpasienter-kan-bli-kurert-med-ny-immunterapi/ 2019-10-30T10:20:56+00:00 https://www.lmi.no/2019/10/30/medisinmangelen-sett-i-gang-med-norsk-produksjon-na/ 2019-10-30T10:22:39+00:00 https://www.lmi.no/2019/10/30/ny-e-helselov-og-endringer-i-ikt-standardforskriften/ 2019-10-30T10:51:31+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_STOR.png https://www.lmi.no/2019/10/30/offentlige-anskaffelser-10-oktober-2019/ 2019-10-30T14:12:32+00:00 https://www.lmi.no/2019/10/30/referat-20-september-2019-2/ 2019-10-30T14:16:42+00:00 https://www.lmi.no/2019/10/29/offentlige-anskaffelser-29-august-2019/ 2019-10-30T14:21:26+00:00 https://www.lmi.no/2019/10/30/aesgp-euro-otc-news-october-2019/ 2019-10-30T14:30:11+00:00 https://www.lmi.no/2019/10/31/har-startet-prisforhandlinger-pa-migrenelegemidler/ 2019-10-31T11:36:55+00:00 https://www.lmi.no/2019/10/31/naer-500-har-trukket-seg-fra-biobank-etter-lovendring/ 2019-10-31T11:38:32+00:00 https://www.lmi.no/2019/10/31/fikk-uhelbredelig-lungekreft-som-30-aring-na-reiser-ekteparet-verden-rundt-for-a-finne-behandling/ 2019-10-31T11:39:57+00:00 https://www.lmi.no/2019/10/31/internasjonalt-samarbeid-om-metodevarsling/ 2019-10-31T11:41:31+00:00 https://www.lmi.no/2019/10/31/innforingen-av-prep/ 2019-10-31T11:43:19+00:00 https://www.lmi.no/2019/11/01/oncoinvent-naermer-seg-studieoppstart-med-radspherin/ 2019-11-01T08:52:14+00:00 https://www.lmi.no/2019/11/01/97-millioner-til-kreftforskning/ 2019-11-01T08:53:34+00:00 https://www.lmi.no/2019/11/01/fikk-behandlingen-nesten-ingen-far/ 2019-11-01T13:11:12+00:00 https://www.lmi.no/2019/11/01/salgstall-fra-farmastat-for-oktober-2019/ 2019-11-01T13:12:04+00:00 https://www.lmi.no/2019/11/04/sykehusinnkjop-inviterer-til-leverandorseminar/ 2019-11-04T09:00:57+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Front-sykehusinnkj.jpg https://www.lmi.no/2019/11/04/ny-gen-terapi-utfordrer-var-etikk-og-vart-prioriteringssystem/ 2019-11-04T09:44:33+00:00 https://www.lmi.no/2019/11/04/merete-43-har-kronisk-migrene-far-radyr-medisin-takket-vaere-spleiselag/ 2019-11-04T09:45:59+00:00 https://www.lmi.no/2019/11/04/england-lanserer-omfattende-forskning-pa-medisinsk-cannabis/ 2019-11-04T09:50:25+00:00 https://www.lmi.no/2019/11/04/ma-satse-pa-curida-for-a-lose-legemiddelmangelen/ 2019-11-04T09:52:53+00:00 https://www.lmi.no/2019/11/04/ny-slankemedisin-det-er-akkurat-som-jeg-har-spist-mye-selv-om-jeg-har-spiste-lite/ 2019-11-04T09:54:13+00:00 https://www.lmi.no/2019/11/04/regjeringen-ma-revurdere-gentesting-av-barn-utenfor-helsevesenet/ 2019-11-04T09:56:54+00:00 https://www.lmi.no/2019/11/04/en-halv-million-dansker-far-ikke-tak-i-legemidlene-sine/ 2019-11-04T09:58:25+00:00 https://www.lmi.no/2019/11/04/vil-ha-lik-behandlingsmulighet-for-alle/ 2019-11-04T10:02:10+00:00 https://www.lmi.no/2019/11/04/lene-hogset-ny-teknisk-sjef-i-msd-animal-health/ 2019-11-04T10:03:33+00:00 https://www.lmi.no/2019/11/04/radioaktiv-medisin-kan-bli-en-norsk-kreftrevolusjon/ 2019-11-04T10:05:23+00:00 https://www.lmi.no/2019/11/01/hostens-lov-og-bransjekurs-2/ 2019-11-04T11:16:42+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Gjengen.jpg https://www.lmi.no/wp-content/uploads/2019/11/Gjengen.jpg https://www.lmi.no/wp-content/uploads/2019/11/aamdalNY.jpg https://www.lmi.no/wp-content/uploads/2019/11/heks.jpeg https://www.lmi.no/2019/11/04/how-to-prepare-for-a-gcp-inspection/ 2019-11-04T14:47:19+00:00 https://www.lmi.no/2019/11/05/pagaende-omorganisering-i-janssen-norge-krever-innlogging/ 2019-11-05T09:11:55+00:00 https://www.lmi.no/2019/11/05/astmaspray-gir-stort-klimaavtrykk/ 2019-11-05T10:03:39+00:00 https://www.lmi.no/2019/11/05/legg-grunnlaget-for-framtidas-kreftbehandling-med-ny-maskin/ 2019-11-05T10:04:59+00:00 https://www.lmi.no/2019/11/05/hvor-forskjellige-kan-generiske-legemidler-vaere/ 2019-11-05T10:06:31+00:00 https://www.lmi.no/2019/11/05/bli-med-i-lmis-miljogruppe/ 2019-11-05T13:54:00+00:00 https://www.lmi.no/wp-content/uploads/2018/05/LEGEMIDLERMILJ%C3%98_digforside-e1572942877542.jpg https://www.lmi.no/wp-content/uploads/2018/09/milj%C3%B8.svg https://www.lmi.no/2019/11/06/e-helse-pa-budsjettet/ 2019-11-06T10:03:02+00:00 https://www.lmi.no/2019/11/06/adele-4-snakker-bare-med-oynene-krever-innlogging/ 2019-11-06T10:04:40+00:00 https://www.lmi.no/2019/11/06/forste-legemiddel-som-kan-bremse-alzheimer/ 2019-11-06T10:06:20+00:00 https://www.lmi.no/2019/11/06/husk-a-melde-deg-pa-strategisamlingen/ 2019-11-06T11:52:19+00:00 https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/2019/11/06/mot-beslutningstagere-pa-helselederforum-2020/ 2019-11-06T14:04:31+00:00 https://www.lmi.no/wp-content/uploads/2019/11/the-climate-reality-project-Hb6uWq0i4MI-unsplash.jpg https://www.lmi.no/2019/11/07/karita-bekkemellem-i-dagbladet-kjaere-lege-bli-heller-kjent-med-industrien/ 2019-11-07T08:27:50+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Karita-Bekkemellem.jpg https://www.lmi.no/2019/11/07/borshopp-for-bergenbio-etter-positive-resultater/ 2019-11-07T09:04:41+00:00 https://www.lmi.no/2019/11/07/kreftsyke-borge-58-om-kontakten-med-helfo-dette-systemet-er-laget-for-at-folk-skal-gi-opp/ 2019-11-07T09:06:32+00:00 https://www.lmi.no/2019/11/07/apenhet-og-tillit-er-en-forutsetning-for-a-lykkes/ 2019-11-07T09:08:32+00:00 https://www.lmi.no/2019/11/07/fem-barn-reddet-etter-utvidet-nyfodt-screening/ 2019-11-07T09:11:21+00:00 https://www.lmi.no/2019/11/07/vil-ha-samarbeid-om-betre-diabetesbehandling/ 2019-11-07T09:13:41+00:00 https://www.lmi.no/2019/11/07/fresenius-kabi-tjente-over-en-halv-milliard-i-fjor-sier-opp-flere-ansatte/ 2019-11-07T10:04:44+00:00 https://www.lmi.no/2019/11/07/politisk-enighet-om-legemiddelmangel-tiltak/ 2019-11-07T15:02:23+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Toppe-og-Stensland.jpg https://www.lmi.no/wp-content/uploads/2019/11/Toppe-og-Stensland.jpg https://www.lmi.no/wp-content/uploads/2019/11/Legemiddelmangelgjengen.jpg https://www.lmi.no/2019/11/08/immunterapi-reddet-livet-mitt/ 2019-11-08T08:35:03+00:00 https://www.lmi.no/2019/11/08/apotek-ansatte-foler-seg-presset-av-interne-salgskonkurranser/ 2019-11-08T08:37:03+00:00 https://www.lmi.no/2019/11/08/voltarol-blir-reseptbelagt/ 2019-11-08T08:38:47+00:00 https://www.lmi.no/2019/11/06/materiellet-for-markedsforing-av-otc-pa-digitale-flater-er-klart/ 2019-11-08T09:21:55+00:00 https://www.lmi.no/wp-content/uploads/2019/09/DSC_8435-e1568704152696.jpg https://www.lmi.no/wp-content/uploads/2019/09/DSC_8435-e1568704152696.jpg https://www.lmi.no/wp-content/uploads/2019/11/13105-designmal-digitale-annonser-LMI_ferdig-03.png https://www.lmi.no/2019/11/08/medietreningskurset-intenst-og-nyttig/ 2019-11-08T10:15:36+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Jacobsen.jpg https://www.lmi.no/wp-content/uploads/2019/11/Studio.jpg https://www.lmi.no/wp-content/uploads/2019/11/Kursholder.jpg https://www.lmi.no/wp-content/uploads/2019/11/Jacobsen.jpg https://www.lmi.no/wp-content/uploads/2019/11/Karita.jpg https://www.lmi.no/2019/11/11/lmis-horingssvar-om-helsedata/ 2019-11-11T15:19:45+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/11/12/startet-sammen-med-veilederne-na-har-de-fatt-resultater-som-viser-at-de-skreddersydde-kreftvaksinene-virker/ 2019-11-12T07:49:56+00:00 https://www.lmi.no/2019/11/12/legemiddelselskap-soker-om-godkjenning-av-den-forste-alzheimer-medisinen-som-skal-kunne-bremse-sykdommen/ 2019-11-12T07:53:16+00:00 https://www.lmi.no/2019/11/12/vil-ha-statlig-produksjon/ 2019-11-12T07:55:09+00:00 https://www.lmi.no/2019/11/12/nar-vi-tvinges-til-a-velge-mellom-hiv-og-migrene/ 2019-11-12T08:06:08+00:00 https://www.lmi.no/2019/11/12/hi-rapport-ingen-funn-av-ulovlige-stoff-ulovlige-legemidler-eller-antibiotika-i-undersokt-oppdrettsfisk/ 2019-11-12T08:09:23+00:00 https://www.lmi.no/2019/11/12/merck-far-godkjent-ebola-vaksinen-ervebo-av-eu-kommisjonen/ 2019-11-12T08:14:05+00:00 https://www.lmi.no/2019/11/12/norsk-professor-advarer-om-amerikansk-studie-pa-paracetbruk-hos-gravide/ 2019-11-12T08:15:58+00:00 https://www.lmi.no/2019/11/12/enighet-om-at-norge-ma-bli-flinkere-til-a-hoste-verdiene-av-forskning/ 2019-11-12T08:27:27+00:00 https://www.lmi.no/wp-content/uploads/2019/11/farmasidagene-monica.jpg https://www.lmi.no/wp-content/uploads/2019/11/farmasidagene-monica.jpg https://www.lmi.no/2019/11/12/apent-mote-om-lungekreft/ 2019-11-12T09:28:34+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Lungekreftm%C3%B8te.png https://www.lmi.no/2019/11/12/mangel-pa-legemidler-til-barn/ 2019-11-12T14:39:16+00:00 https://www.lmi.no/wp-content/uploads/2017/05/legemidler-til-barn2.jpg https://www.lmi.no/wp-content/uploads/2017/05/legemidler-til-barn2.jpg https://www.lmi.no/2019/11/12/lmi-motte-med-naeringskomiteen/ 2019-11-12T15:12:33+00:00 https://www.lmi.no/wp-content/uploads/2019/11/N%C3%A6ringskomite3.jpg https://www.lmi.no/wp-content/uploads/2019/11/N%C3%A6ringskomite3-2.jpg https://www.lmi.no/2019/11/13/legemiddelpodden-er-her/ 2019-11-13T13:54:17+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Karita-Podcast-mindre.jpg https://www.lmi.no/wp-content/uploads/2019/11/Karita-Podcast-mindre.jpg https://www.lmi.no/wp-content/uploads/2019/11/legemiddelpodden_banner.jpg https://www.lmi.no/2019/11/14/kvinner-sliter-med-a-fa-tak-i-livsviktig-vaksine/ 2019-11-14T10:18:04+00:00 https://www.lmi.no/2019/11/14/na-smelter-persontilpasset-medisin-og-e-helse-sammen-nar-vil-helsebransjen-mote-sin-tesla/ 2019-11-14T10:19:37+00:00 https://www.lmi.no/2019/11/15/misforstaelser-om-diabetes-denne-myten-er-direkte-farlig/ 2019-11-15T11:26:55+00:00 https://www.lmi.no/2019/11/15/etterlyser-felles-oversikt-over-medisiner-vil-redde-liv/ 2019-11-15T11:31:09+00:00 https://www.lmi.no/2019/11/15/bent-hoie-vi-velger-ikke-mellom-hiv-og-migrene/ 2019-11-15T11:32:44+00:00 https://www.lmi.no/2017/10/25/antibiotikaresistens-ma-angripes/ 2019-11-15T13:59:14+00:00 https://www.lmi.no/wp-content/uploads/2017/02/Antibiotikaresistens.jpg https://www.lmi.no/wp-content/uploads/2017/02/Antibiotikaresistens-1024x768.jpg https://www.lmi.no/2019/11/18/fornoyd-med-tiltak-i-aps-alternative-budsjett/ 2019-11-18T08:15:37+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Monica2.jpg https://www.lmi.no/wp-content/uploads/2019/04/Monica2.jpg https://www.lmi.no/2019/11/18/kliniske-studier-entusiaster-samlet-i-oslo/ 2019-11-18T09:07:04+00:00 https://www.lmi.no/wp-content/uploads/2019/11/plaza-monica.jpg https://www.lmi.no/wp-content/uploads/2019/11/plaza-monica.jpg https://www.lmi.no/2019/11/18/lyser-ut-mer-penger-til-katapultsentre/ 2019-11-18T10:09:26+00:00 https://www.lmi.no/wp-content/uploads/2019/11/torbj%C3%B8rn-r%C3%B8e-isaksen-e1574071739751.jpg https://www.lmi.no/2019/11/18/champions-league-for-kliniske-studier-norge-ma-med/ 2019-11-18T10:27:17+00:00 https://www.lmi.no/wp-content/uploads/2019/11/kronikkFront.jpg https://www.lmi.no/wp-content/uploads/2019/11/kronikkFront.jpg https://www.lmi.no/2019/11/18/okt-vaksinering-i-oktober/ 2019-11-18T10:57:51+00:00 https://www.lmi.no/2019/11/18/ny-migrenemedisin-kunne-fatt-flere-hundre-i-jobb-hvor-de-bidro-med-skatt-til-statskassa/ 2019-11-18T11:00:54+00:00 https://www.lmi.no/2019/11/18/stortingsdebatt-om-helsenaeringen-se-til-sveits/ 2019-11-18T11:02:14+00:00 https://www.lmi.no/2019/11/18/medisinsk-kunnskap-dobles-hver-72-dag/ 2019-11-18T11:03:44+00:00 https://www.lmi.no/2019/11/18/vil-ha-flere-og-bredere-katapult-sentre/ 2019-11-18T11:08:15+00:00 https://www.lmi.no/2019/11/18/regjeringen-vil-fa-mer-helseindustri-ved-a-teste-nye-medisiner-pa-flere-pasienter/ 2019-11-18T11:09:46+00:00 https://www.lmi.no/2019/11/18/antibiotikabruken-i-storbritansk-oppdrett-redusert-med-naer-70-prosent-krever-innlogging/ 2019-11-18T11:13:49+00:00 https://www.lmi.no/2019/11/18/presentasjoner-fra-drug-safety-forum/ 2019-11-18T14:26:12+00:00 https://www.lmi.no/2019/11/19/stortingshoring-om-statsbudsjettet-legeforeningen-ber-regjeringen-omprioritere/ 2019-11-19T11:21:38+00:00 https://www.lmi.no/2019/11/19/kreft-flere-behandles-flere-lever-lenger-flere-kureres/ 2019-11-19T11:22:53+00:00 https://www.lmi.no/2019/11/19/seks-nye-metoder-kan-tilbys-av-det-offentlige/ 2019-11-19T11:24:15+00:00 https://www.lmi.no/2019/11/19/apotek-fjernar-nasespray-fra-hyllene/ 2019-11-19T11:25:23+00:00 https://www.lmi.no/2019/11/19/fortsetter-omdiskutert-off-label-behandling/ 2019-11-19T11:26:37+00:00 https://www.lmi.no/2019/11/19/grunnmur-pa-plass-for-bygging-av-ny-helsenaering/ 2019-11-19T21:18:29+00:00 https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/wp-content/uploads/2017/01/Karita_portrett.jpg https://www.lmi.no/2019/11/20/salgsstopp-pa-cefotaxim-mip/ 2019-11-20T09:46:06+00:00 https://www.lmi.no/2019/11/20/mange-greip-moglegheita-til-a-beskytte-seg-mot-livmorhalskreft/ 2019-11-20T09:47:56+00:00 https://www.lmi.no/2019/11/20/overrasket-over-ms-vedtak-innskrenker-mulighetene-vare/ 2019-11-20T09:52:47+00:00 https://www.lmi.no/2019/11/20/forsket-ulovlig-pa-nesespray-produsentene-ma-trekke-tilbake-studien/ 2019-11-20T09:54:14+00:00 https://www.lmi.no/2019/11/20/overlege-om-apotekvirksomhet-forurensing-av-helsetjenestene-vare/ 2019-11-20T09:56:49+00:00 https://www.lmi.no/2019/11/20/er-hun-den-neste-helseministeren/ 2019-11-20T09:58:08+00:00 https://www.lmi.no/2019/11/20/europeisk-apotekforening-onsker-felles-miljotiltak-for-apotek/ 2019-11-20T09:59:33+00:00 https://www.lmi.no/2019/11/20/kreftregisteret-lanserer-ny-metadatabank/ 2019-11-20T10:03:14+00:00 https://www.lmi.no/2019/11/20/amoxicillin-mylan-500-mg-kapsler-har-ingen-strekkode/ 2019-11-20T12:22:49+00:00 https://www.lmi.no/2019/11/20/oppsummering-og-kommentarer-til-helsenaeringsmeldingen/ 2019-11-20T14:00:44+00:00 https://www.lmi.no/wp-content/uploads/2019/06/H%C3%B8ring-helsen%C3%A6ringsmeldingen.jpg https://www.lmi.no/wp-content/uploads/2019/06/H%C3%B8ring-helsen%C3%A6ringsmeldingen.jpg https://www.lmi.no/wp-content/uploads/2019/11/N%C3%A6ringskomite3-2.jpg https://www.lmi.no/2019/11/21/lager-32-millioner-kilo-medisin-i-aret/ 2019-11-21T09:00:04+00:00 https://www.lmi.no/2019/11/21/vi-er-ikkje-cowboyar-i-bransjen-og-handla-i-god-tru/ 2019-11-21T09:01:55+00:00 https://www.lmi.no/2019/11/21/bristol-myers-squibb-og-celgene-er-fra-i-dag-ett-selskap/ 2019-11-21T09:03:57+00:00 https://www.lmi.no/2019/11/21/beslutningsforum-utfordrer-pasientsikkerheten-til-mange-tusen-norske-ms-pasienter/ 2019-11-21T09:07:11+00:00 https://www.lmi.no/2019/11/21/medisiner-billigere-i-norge-enn-i-mange-andre-land/ 2019-11-21T09:14:26+00:00 https://www.lmi.no/2019/11/22/skal-vedta-helsenaering/ 2019-11-22T08:33:50+00:00 https://www.lmi.no/2019/11/22/tankevekkende-bok-med-konspiratoriske-stikk/ 2019-11-22T08:36:42+00:00 https://www.lmi.no/2019/11/22/tore-godal-far-kongens-fortenestemedalje/ 2019-11-22T08:38:28+00:00 https://www.lmi.no/2019/11/22/finanskjendisen-har-kjopt-aksjer-for-en-million-i-kragero-bedrift-na-skal-produksjonen-dobles/ 2019-11-22T08:40:04+00:00 https://www.lmi.no/2019/11/22/prioritering-blir-ikke-enklere/ 2019-11-22T08:43:25+00:00 https://www.lmi.no/2019/11/22/marsjordre-til-helseforetakene-fra-stortinget-bruk-innovative-legemiddel-anskaffelser-mer/ 2019-11-22T08:48:46+00:00 https://www.lmi.no/2019/11/22/mulig-ny-kilde-til-antibiotika-funnet-i-havet-lmi-kommenterer/ 2019-11-22T08:52:02+00:00 https://www.lmi.no/2019/11/22/stolte-av-bransjen/ 2019-11-22T12:42:21+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Filmen-Sanofi.jpg https://www.lmi.no/wp-content/uploads/2019/11/Filmen-Sanofi-1.jpg https://www.lmi.no/2019/11/25/offisiell-fusjon-mellom-bms-og-celgene-gjennomfort/ 2019-11-25T08:53:28+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Profilbilde-2-Hilde-B.png https://www.lmi.no/wp-content/uploads/2019/11/Profilbilde-2-Hilde-B.png https://www.lmi.no/2019/11/25/vanlige-medisiner-kan-gi-hoyt-blodtrykk/ 2019-11-25T09:52:16+00:00 https://www.lmi.no/2019/11/25/spetalen-oker-i-vistin-pharma/ 2019-11-25T10:01:57+00:00 https://www.lmi.no/2019/11/25/roche-tecentriq-i-kombinasjon-med-avastin-forlenger-overlevelse-hos-pasienter-med-alvorlig-leverkreft/ 2019-11-25T10:04:40+00:00 https://www.lmi.no/2019/11/25/lungekreftpasienter-lever-mye-lenger-med-immunterapi-vil-endre-behandlingspraksis/ 2019-11-25T10:07:43+00:00 https://www.lmi.no/2019/11/25/na-starter-bygging-pa-radiumhospitalet/ 2019-11-25T10:10:44+00:00 https://www.lmi.no/2019/11/25/ms-syke-elise-katinka-20-kjemper-for-livet-far-ikke-stamcellebehandling-i-norge-ma-reise-til-moskva/ 2019-11-25T10:12:30+00:00 https://www.lmi.no/2019/11/25/styremote-i-lmi-2-desember/ 2019-11-25T10:12:44+00:00 https://www.lmi.no/wp-content/uploads/2019/03/Styret-2019.jpg https://www.lmi.no/wp-content/uploads/2019/04/Veronika-Barrabes-e1559897653464.jpg https://www.lmi.no/2019/11/25/bruk-av-smertestillende-medisin-mangedoblet-i-norge-pa-15-ar/ 2019-11-25T10:14:12+00:00 https://www.lmi.no/2019/11/25/ole-johnny-broholt-bakke-dode-av-en-medisinsk-overdose-33-ar-gammel/ 2019-11-25T10:15:48+00:00 https://www.lmi.no/2019/11/25/forskerne-folger-med-pa-virusresistens-i-norge/ 2019-11-25T10:17:09+00:00 https://www.lmi.no/2019/11/25/kreftlegen-som-endret-kreftpolitikken/ 2019-11-25T10:19:44+00:00 https://www.lmi.no/2019/11/25/innovasjon-norge-stotter-arctic-nutritions-legemiddelutvikling-med-14-millioner-kroner/ 2019-11-25T10:21:47+00:00 https://www.lmi.no/2019/11/25/inspire-gir-et-bedre-og-mer-rettferdig-helsevesen/ 2019-11-25T10:24:34+00:00 https://www.lmi.no/2019/11/25/horing-om-tiltak-for-a-styrke-legemiddelberedskapen/ 2019-11-25T10:26:11+00:00 https://www.lmi.no/2019/11/25/stortingsmelding-om-helsenaeringen/ 2019-11-25T10:27:40+00:00 https://www.lmi.no/2019/11/25/sa-billige-er-medisiner-i-norge/ 2019-11-25T10:29:22+00:00 https://www.lmi.no/2019/11/25/lmi-i-kontaktmote-med-hod/ 2019-11-25T13:55:42+00:00 https://www.lmi.no/wp-content/uploads/2019/11/utenfor.jpg https://www.lmi.no/wp-content/uploads/2019/11/IMG_3971.jpg https://www.lmi.no/2019/11/11/legemiddelmangel-fortvilende-ogsa-for-industrien/ 2019-11-25T15:38:19+00:00 https://www.lmi.no/wp-content/uploads/2019/11/erling-p%C3%A5-farmasidagene.jpg https://www.lmi.no/wp-content/uploads/2019/11/erling-p%C3%A5-farmasidagene.jpg https://www.lmi.no/2019/11/06/tiltak-mot-legemiddelmangel-produksjon-i-norge/ 2019-11-25T15:38:48+00:00 https://www.lmi.no/wp-content/uploads/2019/11/screenshot.jpg https://www.lmi.no/wp-content/uploads/2019/10/Leif-Rune-og-Christian.jpg https://www.lmi.no/2019/10/22/dette-er-en-gledelig-nyhet/ 2019-11-25T15:39:53+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Karita-Bekkemellem.jpg https://www.lmi.no/wp-content/uploads/2019/04/Karita-Bekkemellem.jpg https://www.lmi.no/2019/04/30/horing-om-legemiddelmangel/ 2019-11-26T08:26:53+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Erling1.png https://www.lmi.no/wp-content/uploads/2019/04/ERLING.png https://www.lmi.no/2018/12/13/lmis-horingssvar-om-leveringssviktgebyr/ 2019-11-26T08:29:03+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2018/11/09/alvorlig-problem-feil-losning/ 2019-11-26T08:29:35+00:00 https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/2018/09/28/tiltak-for-a-hindre-penicillinmangel/ 2019-11-26T08:38:23+00:00 https://www.lmi.no/wp-content/uploads/2018/09/pencillin.jpeg https://www.lmi.no/2015/10/26/legemiddelmangel-meld-fra-i-god-tid/ 2019-11-26T08:40:40+00:00 https://www.lmi.no/wp-content/uploads/2017/02/tomme-apotekhyller.gif https://www.lmi.no/wp-content/uploads/2017/02/tomme-apotekhyller.gif https://www.lmi.no/2019/11/26/referat-1-november-2019/ 2019-11-26T08:41:30+00:00 https://www.lmi.no/2019/11/26/altfor-fa-vaksinerer-seg-mot-pollenallergi-mener-forsker/ 2019-11-26T08:47:35+00:00 https://www.lmi.no/2019/11/26/sykehusinnkjop-leveringssikkerhet-teller-30-i-legemiddel-anbudene-lmi-kommenterer/ 2019-11-26T08:49:13+00:00 https://www.lmi.no/2019/11/26/vi-trenger-sterkere-kultur-for-samarbeid-i-helse-norge/ 2019-11-26T08:50:44+00:00 https://www.lmi.no/2019/11/26/goodbye-watson-novo-dropper-samarbeid-med-ibms-kunstige-intelligens/ 2019-11-26T08:56:44+00:00 https://www.lmi.no/2019/11/26/lmis-strategisamling-og-jubileumsfeiring/ 2019-11-26T13:54:55+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Kanon1.jpg https://www.lmi.no/wp-content/uploads/2019/11/Veronika1a.jpg https://www.lmi.no/wp-content/uploads/2019/11/Karita1.jpg https://www.lmi.no/wp-content/uploads/2019/11/Komm1.jpg https://www.lmi.no/wp-content/uploads/2019/11/Pike1.jpg https://www.lmi.no/wp-content/uploads/2019/11/Grupper1.jpg https://www.lmi.no/2019/11/26/staker-ut-kursen-for-en-ny-vekstnaering/ 2019-11-26T22:15:17+00:00 https://www.lmi.no/wp-content/uploads/2019/11/1front.jpg https://www.lmi.no/wp-content/uploads/2019/11/1.jpg https://www.lmi.no/wp-content/uploads/2019/04/Monica2.jpg https://www.lmi.no/2019/11/27/etterforskning-av-legemiddelselskaper-i-usa/ 2019-11-27T09:59:46+00:00 https://www.lmi.no/2019/11/27/pci-biotech-utvider-samarbeid-med-astra-zeneca/ 2019-11-27T10:01:14+00:00 https://www.lmi.no/2019/11/27/en-av-tre-pasienter-er-bekymret-for-legemiddelmangel/ 2019-11-27T10:02:31+00:00 https://www.lmi.no/2019/11/27/hoies-nei-til-ny-migrene-medisin-ga-hanne-40-bakoversveis-det-er-som-a-fa-et-slag-i-trynet/ 2019-11-27T10:03:46+00:00 https://www.lmi.no/2019/11/26/det-digitale-skiftet-hvordan-folger-vi-med/ 2019-11-27T15:06:01+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Tepfers-forsidebilde-e1574867145906.jpg https://www.lmi.no/2019/11/27/dialogmotet-mellom-systemet-for-nye-metoder-og-lmi-ved-helseokonomisk-utvalg/ 2019-11-28T08:38:55+00:00 https://www.lmi.no/2019/11/28/leger-bekymret-for-antibiotikaresistens/ 2019-11-28T09:02:47+00:00 https://www.lmi.no/2019/11/28/transplantasjon-av-avforing-hjalp-mange-med-ibs/ 2019-11-28T09:49:14+00:00 https://www.lmi.no/2019/11/28/vil-fordoble-staben/ 2019-11-28T09:56:20+00:00 https://www.lmi.no/2019/11/28/hivnorge-er-glad-for-bedre-hivmedisiner/ 2019-11-28T09:59:44+00:00 https://www.lmi.no/2019/11/28/produsentene-vil-vite-det-nar-navn-og-pakninger-blir-for-like/ 2019-11-28T10:01:48+00:00 https://www.lmi.no/2019/11/27/helsenaeringsmeldingen-na-ma-vi-bygge-videre/ 2019-11-28T12:19:02+00:00 https://www.lmi.no/wp-content/uploads/2019/11/frontBlogg.jpg https://www.lmi.no/wp-content/uploads/2019/04/Karita-Bekkemellem.jpg https://www.lmi.no/2019/11/28/karita-bekkemellem-i-nytt-helseomsorg21-rad/ 2019-11-28T16:35:32+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Karita-Bekkemellem.jpg https://www.lmi.no/wp-content/uploads/2018/06/Karita_portrett.jpg https://www.lmi.no/2019/11/29/som-a-leve-med-myggstikk-over-hele-kroppen/ 2019-11-29T11:46:52+00:00 https://www.lmi.no/2019/11/29/ny-episode-av-legemiddelpodden-er-ute/ 2019-11-29T13:17:22+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Erling-i-podkaststudio.jpg https://www.lmi.no/wp-content/uploads/2019/11/Erling-i-podkaststudio.jpg https://www.lmi.no/2019/11/29/karita-bekkemellem-jurymedlem-i-helsepitch-konkurranse/ 2019-11-29T14:39:42+00:00 https://www.lmi.no/wp-content/uploads/2019/11/msd_hackaton_2019-227.jpg https://www.lmi.no/wp-content/uploads/2019/11/msd_hackaton_2019-227.jpg https://www.lmi.no/wp-content/uploads/2019/11/msd_hackaton_2019-244.jpg https://www.lmi.no/2019/12/02/lmi-besokte-mericon/ 2019-12-02T08:38:42+00:00 https://www.lmi.no/wp-content/uploads/2019/12/LMI-hos-Mericon.jpg https://www.lmi.no/wp-content/uploads/2019/12/LMI-hos-Mericon.jpg https://www.lmi.no/2019/12/02/slar-alarm-kan-vaere-en-ny-nav-skandale/ 2019-12-02T09:51:41+00:00 https://www.lmi.no/2019/12/02/det-er-ingen-skam-a-snu-bent-hoie/ 2019-12-02T09:54:02+00:00 https://www.lmi.no/2019/12/02/folkehelseinstituttet-tror-det-store-influensautbruddet-kommer-til-jul/ 2019-12-02T09:55:36+00:00 https://www.lmi.no/2019/12/02/alle-nye-hiv-legemidler-blir-fra-i-dag-tilgjengelig-for-norske-pasienter/ 2019-12-02T09:56:49+00:00 https://www.lmi.no/2019/12/02/bare-halvparten-av-kvinnene-benyttet-seg-av-tilbud-om-gratis-vaksine/ 2019-12-02T09:58:22+00:00 https://www.lmi.no/2019/12/02/smertestillande-opioid-er-heilt-naudsynte-etter-operasjonar/ 2019-12-02T09:59:46+00:00 https://www.lmi.no/2019/12/02/likeverdig-og-desentralisert-kreftbehandling-i-hele-helse-sor-ost/ 2019-12-02T10:01:02+00:00 https://www.lmi.no/2019/12/03/forslag-til-ny-lov-skader-pasienter/ 2019-12-03T09:55:58+00:00 https://www.lmi.no/2019/12/03/vil-lovfeste-beslutningsforum-mener-rhf-ene-ma-ha-ansvaret/ 2019-12-03T09:59:34+00:00 https://www.lmi.no/2019/12/03/slv-utsetter-innstramminger-for-verifikasjon-av-legemidler-i-apotek-krever-innlogging/ 2019-12-03T10:01:06+00:00 https://www.lmi.no/2019/12/03/ma-gjore-mer-for-a-sikre-nok-medisiner-i-norge/ 2019-12-03T10:03:01+00:00 https://www.lmi.no/2019/12/03/biotec-pharmacon-leter-etter-kjoper-for-sarbehandling/ 2019-12-03T10:05:02+00:00 https://www.lmi.no/2019/12/03/blir-ny-finansdirektor-i-vistin-pharma/ 2019-12-03T10:06:38+00:00 https://www.lmi.no/2019/12/03/forsker-tror-gluten-kan-forarsake-migrene/ 2019-12-03T10:08:26+00:00 https://www.lmi.no/2019/12/03/legemiddelmangel-2019-var-et-bunnar/ 2019-12-03T10:09:50+00:00 https://www.lmi.no/2019/12/03/hoie-om-legemiddelmangel/ 2019-12-03T10:12:19+00:00 https://www.lmi.no/2019/12/03/medisinmangel-kan-bekjempes-lmi-kommenterer/ 2019-12-03T10:14:46+00:00 https://www.lmi.no/2019/12/03/informasjonsmote-om-effektivisering-av-metodevurderingene/ 2019-12-03T11:23:09+00:00 https://www.lmi.no/wp-content/uploads/2019/12/eksempelbilde_m%C3%B8te.jpg https://www.lmi.no/2019/12/04/velkommen-til-5-nasjonale-konferanse-om-hjertet-og-hjernen/ 2019-12-04T07:58:09+00:00 https://www.lmi.no/2019/12/04/utreder-gratis-hpv-vaksine-til-menn-som-har-sex-med-menn/ 2019-12-04T09:47:59+00:00 https://www.lmi.no/2019/12/04/fra-bagatellgrense-til-nytt-prioriteringskriterium/ 2019-12-04T09:49:39+00:00 https://www.lmi.no/2019/12/04/gunhild-stordalen-et-lite-mirakel/ 2019-12-04T09:51:41+00:00 https://www.lmi.no/2019/12/04/flertall-i-stortinget-for-lovfesting-av-beslutningsforum/ 2019-12-04T09:53:31+00:00 https://www.lmi.no/2019/12/04/det-finnes-sterke-krefter-som-ikke-skyr-noen-midler-for-a-fa-andre-til-a-velge-bort-vaksiner-ikke-la-dem/ 2019-12-04T09:58:59+00:00 https://www.lmi.no/2019/12/04/oppsummering-av-styremote-2-desember/ 2019-12-04T11:23:44+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Veronika-oppsummerer-styrem%C3%B8te-2.-desember.png https://www.lmi.no/2019/12/04/lmi-om-legemiddelmangel-i-ekko/ 2019-12-04T11:38:53+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Erling-i-ekko.jpg https://www.lmi.no/wp-content/uploads/2019/12/Erling-i-ekko.jpg https://www.lmi.no/2019/12/04/karita-bekkemellem-pa-p2/ 2019-12-04T12:14:06+00:00 https://www.lmi.no/wp-content/uploads/2019/12/KaritaP2.jpg https://www.lmi.no/wp-content/uploads/2019/12/KaritaP2.jpg https://www.lmi.no/2019/11/12/slik-skal-vi-stoppe-falske-legemidler/ 2019-12-04T13:18:12+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Farmasidagene-Kai.jpg https://www.lmi.no/wp-content/uploads/2019/11/Farmasidagene-Kai-1.jpg https://www.lmi.no/wp-content/uploads/2019/11/farmasidagene-Line.jpg https://www.lmi.no/2019/12/05/en-av-to-prioriteringer-handler-om-kreft/ 2019-12-05T10:45:48+00:00 https://www.lmi.no/2019/12/05/utskjelt-men-nodvendig/ 2019-12-05T10:47:42+00:00 https://www.lmi.no/2019/12/05/vi-har-ikke-en-sjanse-dersom-forskning-og-industri-ikke-har-tillit-til-hverandre/ 2019-12-05T10:50:58+00:00 https://www.lmi.no/2019/12/05/tarmfloraen-forandrer-legemidler/ 2019-12-05T10:52:38+00:00 https://www.lmi.no/2019/12/05/tecentriq-avastin-kombo-forlenger-overlevelsen-betydelig-for-pasienter-med-alvorlig-leverkreft/ 2019-12-05T10:54:00+00:00 https://www.lmi.no/2019/12/05/foresporsel-om-deltagelse-i-forskningsstudie-av-barnevaksiner/ 2019-12-05T10:55:51+00:00 https://www.lmi.no/2019/12/05/stadig-faerre-dor-av-kreft-og-hjerte-og-karsykdom/ 2019-12-05T10:57:17+00:00 https://www.lmi.no/2019/12/05/innspill-til-styrekandidater/ 2019-12-05T12:19:46+00:00 https://www.lmi.no/wp-content/uploads/2019/03/Styret-2019.jpg https://www.lmi.no/wp-content/uploads/2019/03/Styret-2019.jpg https://www.lmi.no/2019/12/06/ny-rekord-antall-utsendte-doser-influensavaksine-har-passert-1-million/ 2019-12-06T09:19:57+00:00 https://www.lmi.no/2019/12/06/ma-vente-pa-synstap-for-medisinen-dekkes/ 2019-12-06T09:20:22+00:00 https://www.lmi.no/2019/12/06/ny-migrenemedisin-tilgjengelig-fra-mandag/ 2019-12-06T09:20:48+00:00 https://www.lmi.no/2019/12/06/a-jobbe-med-vaksiner-er-en-gavepakke/ 2019-12-06T09:21:14+00:00 https://www.lmi.no/2019/12/06/prises-til-49-milliarder-krever-innlogging/ 2019-12-06T09:32:51+00:00 https://www.lmi.no/2019/12/06/skjema-og-informasjon-om-tillatelse-til-salg-av-utenlandske-pakninger/ 2019-12-06T09:33:17+00:00 https://www.lmi.no/2019/12/04/radet-tilbyr-forhandsuttalelse-om-reklame/ 2019-12-06T13:13:27+00:00 https://www.lmi.no/wp-content/uploads/2019/12/lars-skjermdump-2.jpg https://www.lmi.no/2019/12/09/novartis-kjenner-oss-ikke-igjen-i-historiefortellingen/ 2019-12-09T09:23:59+00:00 https://www.lmi.no/2019/12/09/vaksinerekord-i-norge/ 2019-12-09T09:26:08+00:00 https://www.lmi.no/2019/12/09/pa-tide-med-en-pasientfokusert-ledelse-i-norske-sykehus/ 2019-12-09T09:27:32+00:00 https://www.lmi.no/2019/12/09/referat-10-oktober-2019/ 2019-12-09T12:33:35+00:00 https://www.lmi.no/2019/12/10/kommersialisering-av-forskning-handler-ikke-om-a-gjore-oss-rike/ 2019-12-10T09:44:25+00:00 https://www.lmi.no/2019/12/10/who-vent-med-a-innfore-hpv-vaksine-til-gutter-for-alle-verdens-jenter-far/ 2019-12-10T09:45:56+00:00 https://www.lmi.no/2019/12/10/neste-ar-blir-det-enda-enklere-a-ta-influensavaksinen-i-apotek/ 2019-12-10T09:47:41+00:00 https://www.lmi.no/2019/12/10/referat-29-november-2019/ 2019-12-10T09:50:16+00:00 https://www.lmi.no/2019/12/11/et-eksempel-til-etterfolgelse-innen-kliniske-studier/ 2019-12-11T08:55:13+00:00 https://www.lmi.no/wp-content/uploads/2019/12/frontBlogg2-5.jpg https://www.lmi.no/wp-content/uploads/2019/12/Karita-Bekkemellem.jpg https://www.lmi.no/wp-content/uploads/2019/12/Ole-Kristian-Hjelstuen.jpg https://www.lmi.no/2019/12/11/mener-farmasoyter-bor-kunne-rekvirere-influensavaksine/ 2019-12-11T09:13:39+00:00 https://www.lmi.no/2019/12/11/slik-stiller-du-diagnosen-pa-norske-biotek-selskaper-lmi-kommenterer/ 2019-12-11T09:15:06+00:00 https://www.lmi.no/2019/12/11/link-medical-styrker-staben/ 2019-12-11T10:37:06+00:00 https://www.lmi.no/2019/12/11/link-medical-samarbeider-med-sedana-medical/ 2019-12-11T10:42:53+00:00 https://www.lmi.no/2019/12/10/programmet-er-klart/ 2019-12-11T11:32:13+00:00 https://www.lmi.no/wp-content/uploads/2019/12/front-rwe.jpg https://www.lmi.no/2019/12/11/efpias-policy-dokument-om-nye-pris-og-betalingslosninger/ 2019-12-11T13:05:16+00:00 https://www.lmi.no/2019/12/11/eu-kommisjonens-forslag-til-hta-regulering-pressemelding-fra-efpia/ 2019-12-11T13:08:33+00:00 https://www.lmi.no/2019/12/11/efpias-policy-dokument-om-off-label-bruk-av-okonomiske-hensyn/ 2019-12-11T13:16:56+00:00 https://www.lmi.no/2019/12/12/roche-onsker-a-bidra-til-en-losning-for-pasientene/ 2019-12-12T09:57:22+00:00 https://www.lmi.no/2019/12/12/gir-gratis-konsultasjon-behandling-koster-minst-20-000-i-maneden/ 2019-12-12T09:59:02+00:00 https://www.lmi.no/2019/12/12/annenhver-prioritering-handler-om-kreft/ 2019-12-12T10:02:53+00:00 https://www.lmi.no/2019/12/12/reseptfri-viagra-rives-ut-av-hyllene/ 2019-12-12T10:04:14+00:00 https://www.lmi.no/2019/12/12/temamote-om-likeverdig-og-rask-tilgang-til-legemidler-i-norge/ 2019-12-12T10:23:27+00:00 https://www.lmi.no/wp-content/uploads/2019/11/Sl%C3%B8rdahl.jpg https://www.lmi.no/2019/12/12/dra-forum-presentasjoner-fra-motet-12-nov-2019/ 2019-12-12T11:52:29+00:00 https://www.lmi.no/2019/12/12/nevroklinikken-ous-onsker-industrien-velkommen/ 2019-12-12T12:48:59+00:00 https://www.lmi.no/wp-content/uploads/2019/12/nevro.png https://www.lmi.no/2019/12/13/vaccibody-alle-er-opptatt-av-at-prosjektet-skal-lykkes/ 2019-12-13T08:51:54+00:00 https://www.lmi.no/wp-content/uploads/2019/12/image00001.jpeg https://www.lmi.no/wp-content/uploads/2019/12/image00001.jpeg https://www.lmi.no/wp-content/uploads/2019/12/image00005-1.jpeg https://www.lmi.no/2019/12/13/20-mister-jobben-pa-tpi-norway-det-kan-bli-flere/ 2019-12-13T08:57:58+00:00 https://www.lmi.no/2019/12/13/oppror-mot-ny-pasientlov/ 2019-12-13T08:59:22+00:00 https://www.lmi.no/2019/12/13/legemiddelselskap-tilbyr-gratis-kreftmedisin-men-pasientene-kan-fa-regningen/ 2019-12-13T09:01:07+00:00 https://www.lmi.no/2019/12/13/si-nei-til-nye-metoder/ 2019-12-13T09:07:49+00:00 https://www.lmi.no/2019/12/13/lena-nymo-helli-er-ny-styreleder-i-farmastat/ 2019-12-13T12:26:53+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Lena-Nymo-Helli.jpg https://www.lmi.no/2019/11/19/velkommen-til-helse-og-fremtid-2020/ 2019-12-13T12:34:00+00:00 https://www.lmi.no/wp-content/uploads/2019/11/frontNY-e1574245940810.png https://www.lmi.no/wp-content/uploads/2019/11/qr.png https://www.lmi.no/2019/12/16/lmi-har-levert-innspill-til-handlingsplan-for-kliniske-studier/ 2019-12-16T09:05:04+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Monica1-e1556281225662.jpg https://www.lmi.no/wp-content/uploads/2019/04/Monica1-e1556281225662.jpg https://www.lmi.no/2019/12/16/det-er-som-a-fa-hverdagen-tilbake-igjen/ 2019-12-16T11:28:01+00:00 https://www.lmi.no/2019/12/16/disse-vil-bli-direktor-ved-ous/ 2019-12-16T11:32:52+00:00 https://www.lmi.no/2019/12/16/hoyre-om-lovfesting-av-beslutningsforum/ 2019-12-16T11:34:16+00:00 https://www.lmi.no/2019/12/16/behandlet-omstridt-lovforslag/ 2019-12-16T11:35:46+00:00 https://www.lmi.no/2019/12/16/bruker-lys-for-a-gjore-medisiner-mer-effektive/ 2019-12-16T11:42:30+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Per-Walday.jpg https://www.lmi.no/wp-content/uploads/2019/12/Per-Walday.jpg https://www.lmi.no/2019/12/16/biotek-boom-pa-borsen-sa-naerme-er-selskapene-suksess/ 2019-12-16T11:42:44+00:00 https://www.lmi.no/2019/12/16/ma-kutte-i-investeringer-for-a-ha-nok-penger-til-pasientbehandling/ 2019-12-16T11:45:23+00:00 https://www.lmi.no/2019/12/16/ny-studie-viser-ingen-kobling-mellom-kosthold-midt-i-livet-og-demens/ 2019-12-16T11:46:57+00:00 https://www.lmi.no/2019/12/16/anna-og-signe-emilie-gleder-seg-over-migrenemedisin/ 2019-12-16T11:48:34+00:00 https://www.lmi.no/2019/12/16/viagra-reseptfri-i-salg-fra-i-dag/ 2019-12-16T11:50:20+00:00 https://www.lmi.no/2019/12/16/trakk-sak-om-ms-legemiddel/ 2019-12-16T11:53:16+00:00 https://www.lmi.no/2019/12/16/ny-norsk-oppdagelse-molekyl-kan-bli-ny-medisin-mot-brystkreft/ 2019-12-16T11:54:56+00:00 https://www.lmi.no/2019/12/16/ny-milepael-for-norsk-krefthap/ 2019-12-16T11:56:16+00:00 https://www.lmi.no/2019/12/16/programmet-for-helse-og-fremtid-2020-er-klart/ 2019-12-16T13:24:50+00:00 https://www.lmi.no/wp-content/uploads/2019/12/helse-og-fremtid-2020.jpg https://www.lmi.no/wp-content/uploads/2019/12/helse-og-fremtid-2020.jpg https://www.lmi.no/2019/12/17/novartis-ber-tingretten-avgjore-om-ms-medisin/ 2019-12-17T12:25:44+00:00 https://www.lmi.no/2019/12/17/kreftmedisin-fikk-ja-men-med-restriksjoner/ 2019-12-17T12:26:54+00:00 https://www.lmi.no/2019/12/17/ny-milepael-for-norsk-krefthap-2/ 2019-12-17T12:28:08+00:00 https://www.lmi.no/2019/12/17/forskningsradet-deler-ut-125-milliarder-til-forskning-og-innovasjon-i-naeringslivet/ 2019-12-17T12:29:58+00:00 https://www.lmi.no/2019/12/17/beslutningsforum-ja-til-to-nye-metoder/ 2019-12-17T12:31:28+00:00 https://www.lmi.no/2019/12/17/folk-flest-er-positive-til-likeverdig-bytte-av-legemidler/ 2019-12-17T12:34:16+00:00 https://www.lmi.no/2019/12/17/forteller-om-hverdagen-med-diabetes/ 2019-12-17T12:36:07+00:00 https://www.lmi.no/2019/12/17/norge-som-medisinprodusent/ 2019-12-17T12:42:06+00:00 https://www.lmi.no/2019/12/18/hvordan-kan-pasientforeninger-og-legemiddelindustrien-forbedre-og-oke-samarbeid/ 2019-12-18T09:18:27+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Liten-header.png https://www.lmi.no/wp-content/uploads/2019/12/Header.png https://www.lmi.no/2019/12/18/lena-nymo-helli-starter-firma-for-a-bidra-til-norsk-helseindustri/ 2019-12-18T09:45:31+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Lena-Nymo-Helli-starter-firma.jpg https://www.lmi.no/2019/12/18/nytt-og-felles-soknadsskjema-for-forskningsdata/ 2019-12-18T09:46:52+00:00 https://www.lmi.no/2019/12/18/ny-rekord-antall-utsendte-doser-influensavaksine-har-passert-1-million-2/ 2019-12-18T09:48:37+00:00 https://www.lmi.no/2019/12/18/enkelte-stillehavsoyer-krever-dokumentert-meslingvaksinasjon-for-innreise/ 2019-12-18T09:49:58+00:00 https://www.lmi.no/2019/12/18/msd-animal-health-kjoper-islandsk-utstyrsleverandor/ 2019-12-18T09:51:05+00:00 https://www.lmi.no/2019/12/18/gode-jobbmuligheter-etter-farmasistudiet/ 2019-12-18T09:52:19+00:00 https://www.lmi.no/2019/12/18/vil-ikke-avslore-grunnen-til-ms-utsettelsen/ 2019-12-18T09:53:37+00:00 https://www.lmi.no/2019/12/18/star-norge-pa-terskelen-av-en-egen-opiodkrise/ 2019-12-18T09:54:56+00:00 https://www.lmi.no/2019/12/18/norske-sykehus-er-for-sene-med-a-ta-i-bruk-ny-genteknologi-som-diagnostiserer-kreft/ 2019-12-18T09:56:11+00:00 https://www.lmi.no/2019/12/18/lager-p-pille-som-bare-skal-tas-en-gang-i-maneden/ 2019-12-18T09:57:34+00:00 https://www.lmi.no/2019/12/18/uenighet-om-reseptfri-viagra/ 2019-12-18T09:58:51+00:00 https://www.lmi.no/2019/12/18/norsk-ledet-ebola-vaksine-karet-til-et-av-tiarets-viktigste-forskningsfunn/ 2019-12-18T10:00:09+00:00 https://www.lmi.no/2019/12/18/dette-er-norges-viktigste-biotek-investorer/ 2019-12-18T10:01:25+00:00 https://www.lmi.no/2019/12/18/helsedirektoratet-etablerer-fagrad-for-persontilpasset-medisin/ 2019-12-18T10:04:13+00:00 https://www.lmi.no/2019/12/18/17-desember-vedtaket-var-en-skjellsettende-hendelse/ 2019-12-18T10:05:48+00:00 https://www.lmi.no/2019/12/19/ny-metode-mot-hoyt-kolesterol/ 2019-12-19T11:35:06+00:00 https://www.lmi.no/2019/12/19/terje-soviknes-frp-ny-folkehelseminister/ 2019-12-19T11:36:54+00:00 https://www.lmi.no/2019/12/19/gir-barn-lystgass-pa-sykehuset/ 2019-12-19T11:38:25+00:00 https://www.lmi.no/2019/12/19/hedret-med-diabetesforbundets-forskningspris/ 2019-12-19T11:39:44+00:00 https://www.lmi.no/2019/12/19/solgte-over-45-millioner-vaksiner-til-fisk-i-november/ 2019-12-19T11:41:39+00:00 https://www.lmi.no/2019/12/19/nytt-migrenelegemiddel-pa-refusjon/ 2019-12-19T11:44:40+00:00 https://www.lmi.no/2019/12/19/immunterapi-behandlingsformer-bivirkninger-og-konsekvenser/ 2019-12-19T11:46:11+00:00 https://www.lmi.no/2019/12/19/ebolavaksinen-karet-til-et-av-tiarets-viktigste-gjennombrudd/ 2019-12-19T11:48:29+00:00 https://www.lmi.no/wp-content/uploads/2018/08/ebolavaksine_adobe.jpeg https://www.lmi.no/wp-content/uploads/2018/08/ebolavaksine_adobe.jpeg https://www.lmi.no/wp-content/uploads/2017/10/Ans_Heirman1.jpg https://www.lmi.no/2019/12/20/plassering-av-finansieringsansvar-fra-og-med-1-februar-2020/ 2019-12-20T07:30:43+00:00 https://www.lmi.no/2019/12/20/dine-tarer-kan-avslore-sykdom/ 2019-12-20T09:29:22+00:00 https://www.lmi.no/2019/12/20/anbefaler-at-flere-kvinner-far-ostrogenbehandling/ 2019-12-20T09:30:50+00:00 https://www.lmi.no/2019/12/20/suksess-med-farmasoyter-pa-intensivavdelingene-i-stavanger/ 2019-12-20T09:32:35+00:00 https://www.lmi.no/2019/12/20/flere-norske-jenter-far-angstdiagnose/ 2019-12-20T09:34:20+00:00 https://www.lmi.no/2019/12/20/medisinmangelen-vil-lagre-rastoffer-for-a-produsere-tabletter-selv-i-norge/ 2019-12-20T09:35:46+00:00 https://www.lmi.no/2019/12/20/hvorfor-forer-parkinsons-medisiner-til-spille-og-sexavhengighet/ 2019-12-20T09:37:31+00:00 https://www.lmi.no/2019/12/20/bekymret-over-utfasing-av-legemiddel/ 2019-12-20T09:39:13+00:00 https://www.lmi.no/2019/12/20/horing-om-endringer-i-lua-ordningen/ 2019-12-20T11:14:41+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2019/12/20/monica-larsen-i-fagradet-for-persontilpasset-medisin/ 2019-12-20T11:19:28+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Monica2.jpg https://www.lmi.no/wp-content/uploads/2019/04/Monica2.jpg https://www.lmi.no/2019/12/20/aret-som-har-gatt-3/ 2019-12-20T11:30:41+00:00 https://www.lmi.no/wp-content/uploads/2019/12/julebrevet-2019_bilde-dig-ny.jpg https://www.lmi.no/wp-content/uploads/2019/12/Julebrev-forside-nytt.jpg https://www.lmi.no/2019/12/20/karita-bekkemellem-om-legemiddelproduksjon-pa-p2/ 2019-12-20T11:32:38+00:00 https://www.lmi.no/wp-content/uploads/2019/12/KaritaP2.jpg https://www.lmi.no/wp-content/uploads/2019/12/KaritaP2.jpg https://www.lmi.no/2020/01/02/legemiddelverket-frykter-medisinmangel/ 2020-01-02T08:26:29+00:00 https://www.lmi.no/2020/01/02/lever-med-livmorhalskreft-og-er-evig-optimist/ 2020-01-02T08:28:19+00:00 https://www.lmi.no/2020/01/02/vil-innfore-beredskapsplikt-for-blodfortynnende-medisiner/ 2020-01-02T11:36:37+00:00 https://www.lmi.no/2020/01/03/camilla-stoltenberg-vi-har-gode-helsedata-men-mangler-spilleregler/ 2020-01-03T08:46:36+00:00 https://www.lmi.no/2020/01/03/englands-beslutningsforum-sier-nei-til-kreftlegemiddel-fra-roche-prisen-er-for-hoy/ 2020-01-03T08:55:08+00:00 https://www.lmi.no/2020/01/06/forskning-tau-protein-kan-forutsi-hvordan-hjernen-vil-rammes-av-alzheimer/ 2020-01-06T09:56:23+00:00 https://www.lmi.no/2020/01/06/syv-vaksinenyheter-som-fanget-var-oppmerksomhet-i-2019/ 2020-01-06T09:57:53+00:00 https://www.lmi.no/2020/01/06/dansk-hpv-skandale-avblast-jenter-ble-ikke-syke-av-vaksinen/ 2020-01-06T09:59:19+00:00 https://www.lmi.no/2020/01/06/influensatoppen-er-ventet-i-februar-i-ar-kan-de-minste-bli-mer-utsatt-enn-vanlig/ 2020-01-06T10:00:55+00:00 https://www.lmi.no/2020/01/06/bjorkeallergikere-ma-betale-ny-medisin-selv/ 2020-01-06T10:02:32+00:00 https://www.lmi.no/2020/01/06/nye-tiltak-mot-legemiddelmangel-ma-vaere-mer-malrettet/ 2020-01-06T10:04:07+00:00 https://www.lmi.no/2020/01/06/ny-direktor-i-helse-nord-trondelag/ 2020-01-06T10:05:44+00:00 https://www.lmi.no/2020/01/06/onsker-bedre-tilgang-pa-stoffskiftemedisiner/ 2020-01-06T10:07:27+00:00 https://www.lmi.no/2020/01/06/salgstall-fra-farmastat-for-desember-2019/ 2020-01-06T11:14:30+00:00 https://www.lmi.no/2019/12/20/horing-om-nye-legemidler-pa-beredskapslisten/ 2020-01-06T12:33:27+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2020/01/06/beslutningsforums-konklusjoner-2014-2019/ 2020-01-06T14:52:35+00:00 https://www.lmi.no/2019/07/05/referat-markedstilgangsutvalget-mtu/ 2020-01-07T08:26:28+00:00 https://www.lmi.no/2019/07/01/referat-fra-utvalgsmote/ 2020-01-07T08:28:18+00:00 https://www.lmi.no/wp-content/uploads/2019/07/kelly-sikkema-VBPzRgd7gfc-unsplash.jpg https://www.lmi.no/2020/01/07/helseokonomi-6-september-2019/ 2020-01-07T08:29:33+00:00 https://www.lmi.no/2020/01/07/helseokonomi-24-oktober-2019/ 2020-01-07T08:30:53+00:00 https://www.lmi.no/2020/01/07/markedstilgangsutvalget-12-desember-2019/ 2020-01-07T08:31:39+00:00 https://www.lmi.no/2020/01/07/ingen-fra-apotekfarmasien-i-rad-for-persontilpasset-medisin/ 2020-01-07T09:22:04+00:00 https://www.lmi.no/2020/01/07/astrazenecas-lynparza-far-fda-ja-for-behandling-av-kreft-i-bukspyttkjertelen/ 2020-01-07T09:23:34+00:00 https://www.lmi.no/2020/01/07/norsk-studie-ny-behandling-av-smertefull-leddsykdom/ 2020-01-07T09:25:11+00:00 https://www.lmi.no/2020/01/07/gir-boter-til-selskaper-som-ikke-varsler-om-legemiddelmangel/ 2020-01-07T09:26:33+00:00 https://www.lmi.no/2019/12/19/horing-fra-justis-og-beredskapsdepartementet/ 2020-01-08T08:53:30+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_st%C3%B8rst.png https://www.lmi.no/2020/01/08/fortsatt-okning-i-industriens-omsetning/ 2020-01-08T10:00:42+00:00 https://www.lmi.no/2020/01/08/targovax-inngikk-kinesisk-avtale/ 2020-01-08T10:02:07+00:00 https://www.lmi.no/2020/01/08/diklofenak-tabletter-og-kapsler-blir-reseptpliktig/ 2020-01-08T10:03:43+00:00 https://www.lmi.no/2020/01/08/presentasjoner-fra-informasjonsmote-for-industrien-3-desember-2019/ 2020-01-08T10:05:15+00:00 https://www.lmi.no/2020/01/08/kaller-mangeltiltak-unodvendig-inngripende/ 2020-01-08T10:06:57+00:00 https://www.lmi.no/2020/01/08/velkommen-til-helse-og-fremtid-2020-2/ 2020-01-08T10:38:25+00:00 https://www.lmi.no/wp-content/uploads/2020/01/KaritaFRONTHelse-og-fremtid.jpg https://www.lmi.no/2020/01/08/referat-19-desember-2019/ 2020-01-08T13:29:58+00:00 https://www.lmi.no/2020/01/08/referat-offentlige-anskaffelser-12-desember-2019/ 2020-01-08T13:43:49+00:00 https://www.lmi.no/2020/01/08/karita-bekkemellem-inspirerende-at-solberg-fremhever-helsenaeringen/ 2020-01-08T14:46:42+00:00 https://www.lmi.no/wp-content/uploads/2020/01/nhokonf2020-2.jpg https://www.lmi.no/wp-content/uploads/2020/01/nhokonf2020-2.jpg https://www.lmi.no/2020/01/09/far-millioner-for-a-forske-pa-parkinsons-sykdom/ 2020-01-09T09:11:52+00:00 https://www.lmi.no/2020/01/09/slv-mangeltiltak-krever-okte-ressurser/ 2020-01-09T09:14:13+00:00 https://www.lmi.no/2020/01/06/horing-om-tiltak-for-pa-styrke-legemiddelberedskapen/ 2020-01-09T12:19:30+00:00 https://www.lmi.no/wp-content/uploads/2016/11/H%C3%B8ring-symbol_STOR.png https://www.lmi.no/2020/01/10/uenige-om-monopolsituasjon-pa-stoffskiftemedisiner/ 2020-01-10T08:14:43+00:00 https://www.lmi.no/2020/01/10/slv-godkjente-medisin-mot-parkinsons-pa-blaresept/ 2020-01-10T08:16:31+00:00 https://www.lmi.no/2020/01/10/regjeringen-vil-rasjonere-medisiner-far-hard-kritikk/ 2020-01-10T08:19:36+00:00 https://www.lmi.no/2020/01/13/protonsenter-i-norge-et-kostbart-tiltak-har-fatt-ga-under-radaren/ 2020-01-13T09:49:31+00:00 https://www.lmi.no/2020/01/13/solgte-adhd-tabletter-uten-virkestoff-tilbakekaller-legemidlet/ 2020-01-13T09:51:27+00:00 https://www.lmi.no/2020/01/13/dn-hod-vurderte-habiliteten-til-listhaug-pa-tobakksomradet/ 2020-01-13T09:52:40+00:00 https://www.lmi.no/2020/01/13/viktig-parkinsonsmedisin-pa-bla-resept/ 2020-01-13T09:54:05+00:00 https://www.lmi.no/2020/01/13/viagra-salget-tar-av-i-drammen/ 2020-01-13T09:55:32+00:00 https://www.lmi.no/2020/01/13/9-grep-mot-hoyt-blodtrykk/ 2020-01-13T09:56:49+00:00 https://www.lmi.no/2020/01/13/genene-som-gir-psykiske-lidelser-kan-ogsa-styre-vekta/ 2020-01-13T09:58:07+00:00 https://www.lmi.no/2020/01/13/erna-solberg-kommer-til-elverum-tirsdag/ 2020-01-13T10:00:56+00:00 https://www.lmi.no/2020/01/13/slik-skal-terje-soviknes-gjore-oss-sunnere-og-friskere/ 2020-01-13T10:02:17+00:00 https://www.lmi.no/2020/01/13/sykehuset-ostfold-vil-forske-pa-bruk-av-fleinsopp-mot-depresjon/ 2020-01-13T12:52:10+00:00 https://www.lmi.no/2020/01/13/hoie-har-svart-morland-om-ms-legemidler/ 2020-01-13T14:02:11+00:00 https://www.lmi.no/2019/12/11/fremtidskurset-2020-the-future-of-pharma/ 2020-01-13T14:07:31+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Fremtidskurset_BANNER.jpg https://www.lmi.no/2020/01/14/store-klimaambisjoner-i-life-science/ 2020-01-14T08:41:19+00:00 https://www.lmi.no/2020/01/14/persontilpasset-medisin-eller-presisjonsmedisin/ 2020-01-14T08:43:08+00:00 https://www.lmi.no/2020/01/14/ntnu-skal-prove-a-lose-migrenegaten/ 2020-01-14T08:44:42+00:00 https://www.lmi.no/2020/01/14/cancer-crosslinks-norsk-kreftkonferanse-samler-nasjonal-og-internasjonal-kreftekspertise/ 2020-01-14T08:49:54+00:00 https://www.lmi.no/2020/01/14/sant-eller-usant-holder-vi-pa-a-ga-tom-for-antibiotika/ 2020-01-14T08:51:25+00:00 https://www.lmi.no/2020/01/14/hoie-har-svart-morland-om-ms-legemidler-2/ 2020-01-14T08:52:58+00:00 https://www.lmi.no/2020/01/15/nye-svar-pa-alzheimer-gaten-et-enormt-gjennombrudd/ 2020-01-15T11:32:12+00:00 https://www.lmi.no/2020/01/15/lagspill-til-det-beste-for-befolkningen/ 2020-01-15T11:33:40+00:00 https://www.lmi.no/2020/01/15/global-mangel-pa-hpv-vaksine/ 2020-01-15T11:35:10+00:00 https://www.lmi.no/2020/01/15/sykehustalen-2020-adresserte-for-hoy-arbeidsbelastning/ 2020-01-15T11:36:34+00:00 https://www.lmi.no/2020/01/15/slik-er-de-konkrete-tiltakene-i-regjeringens-strategi-for-kunstig-intelligens/ 2020-01-15T11:48:57+00:00 https://www.lmi.no/2020/01/15/digitalisering-gjor-hverdagen-enklere/ 2020-01-15T11:50:15+00:00 https://www.lmi.no/2020/01/15/erna-solberg-apner-for-at-norge-kan-produsere-mer-medisiner-sjol/ 2020-01-15T11:52:44+00:00 https://www.lmi.no/2020/01/15/selskap-vil-trekke-legemiddel-etter-mistanke-om-okt-kreftrisiko/ 2020-01-15T11:54:05+00:00 https://www.lmi.no/2020/01/15/rekordvaksinering-av-laks-i-2019/ 2020-01-15T11:55:38+00:00 https://www.lmi.no/2020/01/15/mener-slv-selv-ma-vurdere-omfanget-av-apotektilsyn/ 2020-01-15T11:57:51+00:00 https://www.lmi.no/2020/01/15/statsministeren-tilbake-pa-besok-hos-curida/ 2020-01-15T13:57:04+00:00 https://www.lmi.no/wp-content/uploads/2020/01/IMG_9997.jpg https://www.lmi.no/wp-content/uploads/2020/01/IMG_9997.jpg https://www.lmi.no/wp-content/uploads/2020/01/IMG_9963.jpg https://www.lmi.no/wp-content/uploads/2020/01/IMG_9924.jpg https://www.lmi.no/wp-content/uploads/2020/01/IMG_9897.jpg https://www.lmi.no/wp-content/uploads/2020/01/IMG_9879.jpg https://www.lmi.no/wp-content/uploads/2020/01/IMG_9981-1.jpg https://www.lmi.no/2020/01/16/vil-lure-hiv-virus-ut-av-gjemmestedene/ 2020-01-16T10:01:20+00:00 https://www.lmi.no/2020/01/16/reviderte-retningslinjer-for-retur-av-legemidler-fra-apotek-til-salgbart-lager-hos-grossist/ 2020-01-16T10:02:52+00:00 https://www.lmi.no/2020/01/16/alle-barnehager-og-skoler-i-oslo-far-utdelt-jodtabletter/ 2020-01-16T10:05:49+00:00 https://www.lmi.no/2020/01/16/slutt-a-herse-med-verdiskaperne/ 2020-01-16T10:08:12+00:00 https://www.lmi.no/2020/01/16/vakne-opp-fra-oljesovnen/ 2020-01-16T10:54:59+00:00 https://www.lmi.no/wp-content/uploads/2020/01/BrattenClemetBekkemellm2.jpeg https://www.lmi.no/wp-content/uploads/2020/01/BrattenClemetBekkemellm2.jpeg https://www.lmi.no/wp-content/uploads/2020/01/Aleris.jpeg https://www.lmi.no/2020/01/16/arendalsuka-2020/ 2020-01-16T15:27:34+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Arendal-ute-e1556013105907.jpg https://www.lmi.no/wp-content/uploads/2019/04/Arendal-ute-e1556013105907.jpg https://www.lmi.no/2020/01/17/deksametason-injeksjonsvaeske-pa-negativlisten-fra-1-februar-2020/ 2020-01-17T09:31:31+00:00 https://www.lmi.no/2020/01/17/kolesterolmedisiner-skadelig-eller-livsviktig/ 2020-01-17T09:33:14+00:00 https://www.lmi.no/2020/01/17/japan-bekrefter-forste-smittede-av-coronavirus/ 2020-01-17T09:34:39+00:00 https://www.lmi.no/2020/01/17/han-er-ny-ous-direktor/ 2020-01-17T09:36:02+00:00 https://www.lmi.no/2020/01/17/legemiddelverket-tilbyr-online-kurs-i-reklameregelverket/ 2020-01-17T09:37:49+00:00 https://www.lmi.no/2020/01/17/kreftprotonsenter-til-3-milliarder-har-gatt-under-radaren/ 2020-01-17T09:41:09+00:00 https://www.lmi.no/2020/01/17/vaksineguide-stikk-og-reis/ 2020-01-17T09:42:38+00:00 https://www.lmi.no/2020/01/17/disse-to-star-i-fronten-av-internasjonal-kreftforskning/ 2020-01-17T09:45:24+00:00 https://www.lmi.no/2020/01/20/referat-4-desember-2019/ 2020-01-20T07:30:06+00:00 https://www.lmi.no/2019/12/05/referat-10-oktober/ 2020-01-17T13:07:37+00:00 https://www.lmi.no/2019/10/30/referat-3-september/ 2020-01-17T13:08:07+00:00 https://www.lmi.no/2019/01/25/37294/ 2020-01-17T13:08:47+00:00 https://www.lmi.no/2020/01/20/professor-virusforskning-er-oppdrettsbransjens-akilleshael/ 2020-01-20T08:36:30+00:00 https://www.lmi.no/2020/01/20/var-gratis-i-fjor-men-i-ar-ma-ungdom-betale-trist/ 2020-01-20T08:38:00+00:00 https://www.lmi.no/2020/01/20/na-er-ketamin-godkjent-som-legemiddel-mot-depresjon-i-norge/ 2020-01-20T08:39:24+00:00 https://www.lmi.no/2020/01/20/novartis-er-norges-storste-legemiddelfirma-gar-forbi-pfizer-og-msd/ 2020-01-20T08:40:45+00:00 https://www.lmi.no/2020/01/20/helter-og-skurker-i-tv-2-dokumentar-om-behandling-av-septisk-sjokk/ 2020-01-20T08:42:09+00:00 https://www.lmi.no/2015/06/01/informasjon-konseptgodkjenning-arrangementer/ 2020-01-20T10:04:30+00:00 https://www.lmi.no/wp-content/uploads/2015/06/Konseptgodkjenning.jpg